Stockwinners Market Radar for January 24, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
ANET | Hot Stocks20:18 EST Arista Networks CEO sells $8.56M in common stock - In a regulatory filing, Arista Networks disclosed that its CEO Jayshree Ullal sold 32.0K shares of common stock on January 22nd in a total transaction size of $8.56M.
|
DNA | Hot Stocks20:07 EST Cathie Wood's ARK Investment bought 511K shares of Ginkgo Bioworks today
|
RXRX | Hot Stocks20:06 EST Cathie Wood's ARK Investment bought 282.6K shares of Recursion Pharmaceuticals
|
REVB | Hot Stocks19:50 EST Revelation Biosciences Inc trading halted, news pending
|
INO | Hot Stocks19:50 EST Inovio trading halted, news pending
|
KAVL | Hot Stocks19:50 EST Kaival Brands Innovations Group Inc trading halted, news pending
|
BA | Hot Stocks19:01 EST Boeing down 2% afterhours at $210.25 as FAA halts MAX production
|
BA | Hot Stocks19:01 EST FAA halts Boeing's MAX aircraft production - The Federal Aviation Administration announces: "The January 5 Boeing 737-9 MAX incident must never happen again. Accordingly, the Federal Aviation Administration is announcing additional actions to ensure every aircraft is safe. The FAA today informed Boeing it will not grant any production expansion of the MAX, including the 737-9 MAX. This action comes on top of the FAA's investigation and ramped up oversight of Boeing and its suppliers. The FAA today also approved a thorough inspection and maintenance process that must be performed on each of the grounded 171 Boeing 737-9 MAX aircraft. Upon successful completion, the aircraft will be eligible to return to service. The FAA approved this detailed set of inspection and maintenance instructions after a thorough review of data from 40 inspections of grounded planes. The FAA also convened a Corrective Action Review Board, or CARB. The CARB, made up of safety experts, scrutinized and approved the inspection and maintenance process. Following the completion of the enhanced maintenance and inspection process on each aircraft, the door plugs on the 737-9 MAX will be in compliance with the original design which is safe to operate. This aircraft will not operate until the process is complete and compliance with the original design is confirmed." Reference Link
|
FBMS | Hot Stocks18:51 EST First Bancshares raises quarterly dividend 4% to 25c per share - First Bancshares announced that its Board of Directors declared a cash dividend of 25c per share, a 4% increase over previous quarter, per share to be paid on its common stock on February 23, 2024 to shareholders of record as of the close of business on February 7, 2024.
|
META | Hot Stocks18:27 EST Meta Platforms COO sells $3.5M in common stock - In a regulatory filing, Meta Platforms disclosed that its COO Javier Olivan sold 9K shares of common stock on January 22nd in a total transaction size of $3.5M.
|
IBM | Hot Stocks18:15 EST IBM sees workforce rebalancing 'consistent with what played out in 2023'
|
TSLA | Hot Stocks18:09 EST Tesla CEO says will start next-gen compact vehicle production toward end of 2025
|
TSLA | Hot Stocks18:05 EST Tesla CFO says intend to continue cost reduction efforts in 2024 - CFO Vaibhav Taneja says: "For 2024, our focus is to continue growing our output, continuing our cost reduction efforts and increasing investments in our future growth initiatives. Accordingly, we are currently expecting our capital expenditure for 2024 to be in excess of $10 billion" vs. $8.9B in 2023.
|
TSLA | Hot Stocks18:00 EST Tesla CEO says 'very far along' on our next-generation low-cost vehicle
|
TSLA | Hot Stocks17:58 EST Tesla CEO says to continue to see strong growth in energy storage - Tesla CEO Elon Musk states: "The energy storage business delivered nearly 15 gigawatt hours of batteries in 2023 compared to 6.5 gigawatt hours the year before, so tremendous year-over-year growth, triple digits. And yes, I think we'll continue to see very strong growth in storage, as predicted. I said for many years that the storage business will grow much faster than the car business, and it is doing that." Comments taken from Q4 earnings conference call.
|
LVS | Hot Stocks17:52 EST Las Vegas Sands to purchase approximately $250M of SCL common stock - "We also entered into an agreement to purchase approximately $250 million of SCL common stock that will be completed in the first half of 2024."
|
HPE | Hot Stocks17:41 EST HP Enterprise shares fall after nation-state actor Midnight Blizzard hack - Shares of Hewlett Packard Enterprise are down approximately 1% or 16c per share to $15.60 per share after the company said it was hacked by group thought to be Midnight Blizzard. "On December 12, Hewlett Packard Enterprise Company was notified that a suspected nation-state actor, believed to be the threat actor Midnight Blizzard, the state-sponsored actor also known as Cozy Bear, had gained unauthorized access to HPE's cloud-based email environment," added the company in a release.
|
IBM | Hot Stocks17:35 EST IBM says 'laser focused' on productivity initiatives - Says targeting $3B in annual run rate savings by end of 2024. Says ended year with strong liquidity position. Says seeing growing interest in generative AI platform. Says software, consulting currently represent about 75% of the company's revenue base. Expects Q1 revenue growth rate similar to full year growth rate.
|
CRM | Hot Stocks17:24 EST Salesforce Chairman Benioff sells over $4M in shares - Chairman of Salesforce Marc Benioff diclosed the sale of 15,000 shares of company stock at $277.96 per share on January 23 for a total transaction amount of $4,169,426.
|
STX | Hot Stocks17:22 EST Seagate says September quarter will be bottom of down cycle - Says revenue was led by cloud and airline demand in Q2. Says September quarter will be bottom of current down cycle. Says anticipated relatively slower pace of recovery in China. Says Comments taken from Q2 earnings conference call.
|
NBN | Hot Stocks17:17 EST Northeast Bank names Richard Cohen CFO - Northeast Bank announced the hiring of Richard Cohen, who will be appointed as Chief Financial Officer of the Bank, effective February 1, 2024. Cohen will succeed Chief Financial Officer Jean-Pierre Lapointe upon his departure from the Bank. Cohen joins the Bank directly from Grey Matter Thinking, a professional services business that has specialized in banking since 2008, where he was the founder and Chief Executive Officer. Prior to that, he was a Partner in KPMG's Financial Services Practice in Johannesburg and subsequently in London. Mr. Cohen holds two Bachelors' degrees and one Master's degree in Commerce, as well as a Postgraduate Diploma in Accounting. He is a qualified Chartered Accountant, and a CFA Charterholder. Northeast Bank President and Chief Executive Officer Rick Wayne said "Richard's impressive background and breadth of experience in the financial services industry will make him a great fit for Northeast Bank. We welcome him to our team and look forward to his contributions to the Bank."
|
BA | Hot Stocks17:16 EST Boeing awarded $102.73M Navy contract modification - Boeing was awarded a $102.73M cost-plus-fixed-fee modification to an order against a previously issued basic ordering agreement. This modification exercises options for the production and delivery of ten P-8A increment three retrofit A-kits and provides for three retrofit kit A-kit installs, in support of anti-submarine warfare capabilities upgrades for the Navy. Work is expected to be completed in November 2026. FY24 aircraft procurement funds in the amount of $102.73M will be obligated at the time of award, none of which will expire at the end of the current fiscal year. Naval Air Systems Command is the contracting activity.
|
GM | Hot Stocks17:15 EST GM to invest $1.4B in Brazil to deliver a new generation of ICE vehicles - General Motors announced today a R$7 B or $1.4B investment in its plants and operations in Brazil to deliver a new generation vehicle portfolio for customers in South America. The investment is primarily focused on production facility upgrades in Brazil to deliver a new generation of locally produced internal combustion engine ICE vehicles, as well as a portfolio of imported ICE and electric vehicles. GM Senior Vice President and President of GM International Shilpan Amin and GM South America President and Managing Director Santiago Chamorro made the announcement in Brasilia, Brazil, following a meeting with the President of the Republic of Brazil, Luiz Inacio Lula da Silva. "With our long history and investments for the future, Brazil is a critical market for our growing GM business," said Amin. Reference Link
|
IBM | Hot Stocks17:12 EST IBM says 'confident' in achieving mid term revenue model - Expects many macro trends "similar to 2023." Says clients looking to boost productivity via AI. Says company's approach to AI in business is "resonating." Expects consulting business to be early beneficiary of AI. Saw "meaningful consulting wins" in Q4. Comments taken from Q4 earnings conference call.
|
ADT | Hot Stocks17:06 EST ADT Inc. provides update on capital allocation strategy - ADT Inc. has authorized a $350M share repurchase program. As the company executes share repurchases, the Board will periodically review the remaining authorization as part of its capital allocation strategy. On December 29, 2023, the company repaid $500M of First Lien Senior Secured Notes due 2024, completing an overall 2023 reduction of ADT's total debt by approximately $2B. Following two corporate rating upgrades in 2023, the company improved borrowing costs and extended debt maturities and in 2024, will have $150M of maturities and amortization payments. The company remains focused on achieving its targeted net leverage ratio of less than 3.0x. On December 20, 2023, the company closed on a strategic bulk purchase of approximately 57,000 customer accounts for $89M cash with attractive returns. This portfolio of customers is concentrated in a few key geographies, all of which align with existing platforms, enabling strong economies of scale upon integration. This transaction was not included in prior cash flow guidance.
|
TOWN | Hot Stocks17:04 EST TowneBank reports Q4 net interest margin 3.03% vs. 3.08% last year - Q4 provision for credit losses was an expense of $2.45M in the current quarter and $1.01M in the linked quarter, compared to $6.07M one year ago.
|
ADT | Hot Stocks17:04 EST ADT Inc. increases quarterly cash dividend 57% to 5.5c per share - ADT Inc. has declared a quarterly cash dividend of 5.5c per share, payable on April 4 to shareholders of record at the close of business on March 14. The quarterly dividend represents a 57% increase over the previous quarterly dividend.
|
ADT | Hot Stocks17:03 EST ADT Inc. exiting residential solar business - ADT Inc. will be exiting its residential solar business. The company will remain focused on cash flow generation and capital-efficient growth within its core security and smart home business. ADT is also advancing its capital allocation strategy, including a cash dividend increase and authorization of a new share repurchase program. Over the first nine months of 2023, the solar business faced challenges, including operational difficulties and macroeconomic headwinds causing deterioration of conditions industrywide. As a result of these challenges, the Solar segment generated an Adjusted EBITDA loss of $89M during this period. ADT's Board of Directors has approved the exit of this segment, which may include the transfer of components of the business to other parties. The company expects to incur certain one-time exit charges and cash expenditures with potential offsets from asset sales or reduced tax expenses. At this time, the company is still analyzing the estimated net amount or range of amounts expected to be incurred in connection with this plan.
|
HPE | Hot Stocks17:02 EST HPE was hacked by group thought to be Midnight Blizzard - On December 12, Hewlett Packard Enterprise Company was notified that a suspected nation-state actor, believed to be the threat actor Midnight Blizzard, the state-sponsored actor also known as Cozy Bear, had gained unauthorized access to HPE's cloud-based email environment. "The Company, with assistance from external cybersecurity experts, immediately activated our response process to investigate, contain, and remediate the incident, eradicating the activity. Based on our investigation, we now believe that the threat actor accessed and exfiltrated data beginning in May 2023 from a small percentage of HPE mailboxes belonging to individuals in our cybersecurity, go-to-market, business segments, and other functions. While our investigation of this incident and its scope remains ongoing, the Company now understands this incident is likely related to earlier activity by this threat actor, of which we were notified in June 2023, involving unauthorized access to and exfiltration of a limited number of SharePoint files as early as May 2023. Following the notice in June, we immediately investigated with the assistance of external cybersecurity experts and took containment and remediation measures intended to eradicate the activity. Upon undertaking such actions, we determined that such activity did not materially impact the Company. We have notified and are cooperating with law enforcement and are also assessing our regulatory notification obligations, and we will make notifications as appropriate based on our investigation findings. As of the date of this filing, the incident has not had a material impact on the Company's operations, and the Company has not determined the incident is reasonably likely to materially impact the Company's financial condition or results of operations," said the company in an 8K regulatory filing. Reference Link
|
CADE | Hot Stocks17:01 EST Cadence Bank raises quarterly dividend to 25c from 24c per share - The common stock dividend is payable on April 1, 2024, to shareholders of record at the close of business on March 15, 2024.
|
GTLB | Hot Stocks16:56 EST GitLab CFO sells $5.29M in common stock - In a regulatory filing, GitLab disclosed that its CFO Brian Robins sold 75K shares of common stock on January 22nd in a total transaction size of $5.29M.
|
NVTA | Hot Stocks16:42 EST Invitae expects $4M in charges in Q1 from workforce reduction - As previously announced and in connection with the consummation of the transaction described under Item 1.01 of the Original Report, Invitae had initiated a workforce reduction. At the time of the Original Report, the company was not able to estimate one-time severance related charges. The company expects to incur one-time severance related charges of approximately $4M in the quarter ending March 31, 2024, the company said in a regulatory filing.
|
FSBW | Hot Stocks16:40 EST FS Bancorp announces 4% boost to dividend to 26c per share - "Utilizing the Bank's highly diversified balance sheet, our team achieved our goal of producing strong financial results in varying rate and economic environments," stated Joe Adams, CEO. "We are also pleased that our Board of Directors increased and approved our forty-fourth consecutive quarterly cash dividend. The quarterly dividend will be paid on February 22, 2024, to shareholders of record as of February 8, 2024," concluded Adams. "The integration of the seven retail branches acquired from Columbia State Bank in the first quarter of 2023, provided a framework for our balanced, focused growth throughout 2023," noted Matthew Mullet, CFO.
|
SLM | Hot Stocks16:38 EST SLM board approves new $650M share repurchase program
|
OST | Hot Stocks16:38 EST Ostin Technology receives noncompliance notification from Nasdaq - Ostin Technology announced that the company had received a written notification from the staff of the Listing Qualifications Department of Nasdaq, indicating that for the last 30 consecutive business days, the closing bid price for the company's ordinary shares was below the minimum bid price of $1.00 per share requirement set forth in Nasdaq Listing Rule 5550(a)(2).
|
SLM | Hot Stocks16:37 EST SLM reports Q4 private education loan originations of $839M, up 2%. - Reports Q4 average private education loans outstanding of $21.1 billion, up 4%, and private education loan provisions for credit losses, including amounts for unfunded commitments, was $16 million, compared with a provision of $297 million.
|
MATV | Hot Stocks16:31 EST Mativ announces organizational realignment, first wave 'driven by' layoffs - Mativ Holdings announced organizational realignment initiatives that will streamline organizational size and complexity, and leverage business-critical resources to enhance customer support. As a result of these initiatives, the Company expects to achieve an annualized run-rate of $20 million of overhead cost reduction in 2024 and an additional $20 million by the end of 2026, effectively reducing overhead costs by approximately 15% over that timeframe. The first wave of this initiative is primarily driven by workforce reductions and indexed toward senior levels of the organization. The second wave of savings will be unlocked by system integrations, further restructuring, and transactional efficiencies. The 2024 charges associated with these initiatives are estimated to be $15-$20 million, which are expected to be incurred predominantly in the first half of 2024. As part of the realignment, the Company will reorganize into two new segments starting in Q1 2024: Filtration & Advanced Materials, focused primarily on filtration and protective solutions end markets, and Sustainable & Adhesive Solutions, focused primarily on release liners, industrials, healthcare, and packaging and specialty papers end markets. Christoph Stenzel, Filtration President, has been promoted to Group President, Filtration & Advanced Materials, and Ryan Elwart will join Mativ as Group President, Sustainable & Adhesive Solutions, effective as of January 30, 2024. Mr. Elwart joins Mativ from Georgia-Pacific, where he spent the last 16 years in roles of increasing responsibility, most recently as Chief Customer Officer of Georgia-Pacific's Consumer Products division.
|
KBH | Hot Stocks16:29 EST KB Home names Robert McGibney president, COO - KB Home announced that Robert McGibney has been promoted to President in addition to his current role of Chief Operating Officer, effective February 1, 2024. In this expanded position, Mr. McGibney will continue to have overall responsibility for the Company's operations, while also directing business strategy, community count and revenue growth, along with leadership development. Additionally, Mr. McGibney will continue to lead key strategic support functions such as architecture, design studio, marketing, national contracts, sustainability, and financial services operations. "I am pleased to announce Rob's promotion, which will further support our planned increase in community count this year, and position the Company for future revenue growth," said Jeffrey Mezger, Chairman and Chief Executive Officer. "Rob joined KB Home over two decades ago and is a great example of our ability to grow talent within the Company. He has done a tremendous job building robust businesses across our footprint and has been an outstanding operator throughout his KB Home career. Rob's appointment to President, along with several regional management additions, are important steps in structuring our team to take full advantage of the opportunities available to us and achieving our strategic goal of top 5 or better market share position in each of our served markets."
|
AFYA | Hot Stocks16:29 EST Afya announces medical seats increase in FIP Guanambi - Afya Limited announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education authorized the increase of 40 medical seats of Faculdades Integradas Padrao, in the city of Guanambi, located in the state of Bahia, which will result in an additional payment of R$49.6B. With the authorization, Afya reaches 100 medical seats on this campus, and 3,203 total approved seats.
|
F | Hot Stocks16:22 EST Ford sees Q4 pre-tax remeaurement loss of $1.7B related to pension and OPEB plan - The company states: "Ford Motor Company uses the mark-to-market method of accounting for pension and other postretirement employee benefits, or OPEB. Under this method, we recognize pension and OPEB remeasurement gains and losses in income when incurred rather than amortizing them over time as a component of net periodic benefit cost. The remeasurement gains and losses are reported as special items since we believe they are not reflective of our ongoing operating activities. We expect to record a pre-tax remeasurement loss in our fourth quarter 2023 results of approximately $1.7 billion related to our pension and OPEB plans. This includes a $0.5 billion loss associated with pension plans in the United States, a $0.9 billion loss associated with pension plans outside the United States, and a $0.3 billion loss associated with OPEB plans globally. The remeasurement loss was largely driven by lower discount rates compared to year-end 2022, partially offset by asset gains in excess of our assumptions. On an after-tax basis, the remeasurement is expected to decrease our net income by about $1.3 billion as we will record a net tax benefit based on the tax rates in the jurisdictions where there are remeasurement gains and losses. Because the remeasurement is a special item, it will not impact our total Company adjusted EBIT or adjusted earnings per share. The remeasurement did not have an impact on our cash in 2023, and does not change our expectations for pension contributions in 2024. In aggregate, our funded plans remain fully funded. Including the impact of remeasurement gains and losses during 2023, we expect the underfunded status for our pension and OPEB plans to be about $2.3 billion and $4.7 billion, respectively, at year-end 2023, compared with $0.2 billion and $4.5 billion, respectively, at year-end 2022. The change to the underfunded status of our plans in the aggregate primarily reflects the impact of the remeasurement loss."
|
URI | Hot Stocks16:21 EST United Rentals boosts quarterly dividend by 10% to $1.63 per share - United Rentals said its board is increasing the company's quarterly dividend by 10% and has declared a quarterly dividend of $1.63 per share, payable on February 28, to stockholders of record on February 14.
|
F | Hot Stocks16:20 EST Ford sees Q4 pre-tax remeaurement loss of $1.4B related to pension and OPEB plan - The company states: "Ford Motor Company uses the mark-to-market method of accounting for pension and other postretirement employee benefits, or OPEB. Under this method, we recognize pension and OPEB remeasurement gains and losses in income when incurred rather than amortizing them over time as a component of net periodic benefit cost. The remeasurement gains and losses are reported as special items since we believe they are not reflective of our ongoing operating activities. We expect to record a pre-tax remeasurement loss in our fourth quarter 2023 results of approximately $1.7 billion related to our pension and OPEB plans. This includes a $0.5 billion loss associated with pension plans in the United States, a $0.9 billion loss associated with pension plans outside the United States, and a $0.3 billion loss associated with OPEB plans globally. The remeasurement loss was largely driven by lower discount rates compared to year-end 2022, partially offset by asset gains in excess of our assumptions. On an after-tax basis, the remeasurement is expected to decrease our net income by about $1.3 billion as we will record a net tax benefit based on the tax rates in the jurisdictions where there are remeasurement gains and losses. Because the remeasurement is a special item, it will not impact our total Company adjusted EBIT or adjusted earnings per share. The remeasurement did not have an impact on our cash in 2023, and does not change our expectations for pension contributions in 2024. In aggregate, our funded plans remain fully funded. Including the impact of remeasurement gains and losses during 2023, we expect the underfunded status for our pension and OPEB plans to be about $2.3 billion and $4.7 billion, respectively, at year-end 2023, compared with $0.2 billion and $4.5 billion, respectively, at year-end 2022. The change to the underfunded status of our plans in the aggregate primarily reflects the impact of the remeasurement loss."
|
URI | Hot Stocks16:20 EST United Rentals announces 'enhanced capital allocation strategy' - United Rentals said its board "approved an enhanced capital allocation strategy that remains focused on balancing growth and returns." The company's new balance sheet strategy includes lowering its targeted full-cycle leverage range to 1.5x-2.5x from the range of 2.0x-3.0x adopted in 2019. The company's net leverage ratio was 1.6x as of December 31, 2023. Matthew Flannery, CEO of United Rentals, said, "After thorough evaluation over the last year, including cost-benefit analysis of the balance sheet strategy we introduced in 2019, we are very pleased to be introducing our updated strategy that we expect will serve both our company and our investors well. This change remains consistent with other actions we've taken to deploy our capital with a balanced approach to growing our business, while also improving our financial strength and flexibility with the ultimate goal of driving shareholder value."
|
URI | Hot Stocks16:20 EST United Rentals announces new $1.5B share repurchase program - United Rentals said its board authorized a new $1.5B share repurchase program that is expected to be completed by the end of the first quarter of 2025. The company plans to begin repurchases under the program during Q1 of 2024, following completion of its existing $1.25B share repurchase program. In total, the company intends to complete $1.5B of share repurchases in 2024, with the remaining $250M of the new authorization carried into 2025.
|
BCC | Hot Stocks16:19 EST Boise Cascade to invest additional $140M to support EWP growth strategy - Boise Cascade announced new investments in Alabama and Louisiana in support of its engineered wood products growth strategy. In Alabama, the company is adding I-joist production capabilities to its Thorsby EWP mill and converting a plywood layup line to a parallel laminated veneer line at the Chapman plywood facility. The Chapman investment adds to its important integration into the company's EWP growth plans. In addition, the Chapman plywood facility extended employment opportunities to approximately 50 of the 80 associates affected by the recently announced Chapman lumber operations curtailment. At its Oakdale, Louisiana facility, major projects planned include the upgrade and redesign of the log utilization center, a new veneer dryer and press, and modification of an existing veneer dryer. These investments are expected to take place over a two-year period. "We are looking forward to these major expansions and upgrades to further solidify our market position in EWP," said Chris Seymour, SVP, Wood Products Manufacturing Operations. "We have great teams in the southeastern U.S. and are pleased to further invest in our meaningful asset bases in Alabama and Louisiana." On a total company basis, the company's current estimate of capital expenditures for 2024 is $250M to $270M. This range includes the investments above and spending on the previously announced greenfield distribution centers in Hondo, Texas and Walterboro, South Carolina in our Building Materials Distribution segment.
|
VTOL | Hot Stocks16:18 EST Bristow Group enters into new long-term equipment financing for up to GBP55M - Bristow Group has entered into a new twelve-year secured equipment financing for an aggregate amount up to GBP55M with a syndicate of banks led by National Westminster Bank. The proceeds from the financing will be used to support Bristow's capital commitments related to the 2nd generation UK search and rescue contract with the Department for Transport and the Maritime & Coastguard Agency of the United Kingdom. Bristow's obligations will be secured by four new-delivery AgustaWestland AW139 search and rescue helicopters. The credit facility has a 15-month availability period and is expected to fund during 2024, subject to delivery of the new SAR helicopters.
|
IBM | Hot Stocks16:17 EST IBM jumps 5% to $182.25 after Q4 results beat estimates
|
AJG | Hot Stocks16:16 EST Arthur J. Gallagher raises quarterly dividend to 60c from 55c per share - The dividend will be payable on March 15 to Stockholders of Record as of March 1.
|
IBM | Hot Stocks16:14 EST IBM CEO says grew revenue in all segments in Q4 - "In the fourth quarter, we grew revenue in all of our segments, driven by continued adoption of our hybrid cloud and AI offerings. Client demand for AI is accelerating and our book of business for watsonx and generative AI roughly doubled from the third to the fourth quarter," said Arvind Krishna, IBM chairman and CEO. "For the year, revenue growth was in line with our expectations, and we exceeded our free cash flow objective. Based on the strength of our portfolio and demonstrated track record of innovation, for 2024 we expect revenue performance in line with our mid-single digit model and about $12 billion in free cash flow."
|
IXHL | Hot Stocks16:13 EST Incannex: Dosing commenced in HCQ-CBD combo IHL-675A in patients with RA - Incannex Healthcare is pleased announces that patient dosing has commenced in the Phase 2 clinical trial assessing IHL-675A in patients with rheumatoid arthritisor RA . IHL-675A is the Company's proprietary combination drug candidate composed of Hydroxychloroquine Sulphate , HCQ and cannabidiol CBD , both of which have well characterized anti-inflammatory activity when administered individually. The primary endpoint of the double-blind, Phase 2 clinical trial is pain and function relative to baseline determined via the score on the RAPID-3 assessment at 24 weeks. The trial will enroll 128 participants across 10 study sites in Australia with participants receiving either IHL-675A, CBD, HCQ or placebo. Participants will record their pain and function outcomes daily, by completing questionnaires on pain, fatigue, joint stiffness, and quality of life, using an electronic Patient Reported Outcomes device. Chief Scientific Officer of Incannex, Dr. Mark Bleackley, said; "Commencing dosing in the Phase 2 clinical trial in patients with RA is an exciting milestone for the development of IHL-675A. Millions of people are affected by pain associated with rheumatoid arthritis despite the available treatment options. IHL-675A has the potential to address this unmet need. We look forward to generating data on the safety and efficacy of IHL-675A and sharing this data with FDA and other regulatory agencies."
|
NOW | Hot Stocks16:13 EST ServiceNow sees Q1 subscription revenue growth 23.5%-24%
|
LVS | Hot Stocks16:12 EST Las Vegas Sands reports Q4 Macao Adjusted Property EBITDA of $654M - Low Hold on Rolling Play in Macao Negatively Impacted Adjusted Property EBITDA by $40M. Reports Marina Bay Sands Adjusted Property EBITDA of $544M - High Hold on Rolling Play at Marina Bay Sands Positively Impacted Adjusted Property EBITDA by $71M.
|
WRB | Hot Stocks16:12 EST W. R. Berkley reports Q4 EPS $1.45, consensus $1.38 - Reports Q4 revenue $3.22B, consensus $3.21B. The Company commented: "Our Company completed another record-setting year in 2023, achieving a 23.6% annualized return on beginning equity in the fourth quarter. Our quarter and full year results were characterized by growth in net premiums written, along with record underwriting performance and net investment income. Book value per share grew 11.6% during the fourth quarter, before the return of $264 million of capital to shareholders through special and ordinary dividends and share repurchases. Growth in net premiums written accelerated to 12% in the fourth quarter, as we deployed capital in areas of the business that we expect to achieve or exceed our targeted risk-adjusted return on equity. In a market where lines of business increasingly move independently from each other, our decentralized structure provides us with a competitive advantage that allows us to better navigate risks and embrace opportunities. Net investment income from our fixed-maturity portfolio increased more than 50% during the quarter and 60% for the year as our portfolio grew and we (re)invested at higher interest rates. The current rates at which we can reinvest remains higher than our annual book yield, and record operating cash flow positions us well for future investment income growth. Our Company performed exceptionally well during 2023, and we anticipate 2024 will continue to be rewarding for our shareholders. We view the current property and casualty insurance and investment environments as favorable to our business model. We are confident that we will continue to deliver superior long-term risk-adjusted returns and increase value to shareholders in 2024 and beyond."
|
IBM | Hot Stocks16:11 EST IBM reports Q4 cash from operating activities of $4.5B - In the fourth quarter, the company generated net cash from operating activities of $4.5 billion, up $0.5 billion year to year. Net cash from operating activities excluding IBM Financing receivables was $6.3 billion. IBM's free cash flow was $6.1 billion, up $0.9 billion year to year. The company returned $1.5 billion to shareholders in dividends in the fourth quarter.
|
TSLA | Hot Stocks16:11 EST Tesla down 3% after Q4 earnings miss - Tesla shares are down $6.85, or 3%, to $200.98 in after-hours following the company's Q4 report and ahead of its associated earnings call.
|
NOW V | Hot Stocks16:10 EST ServiceNow enters 5-year alliance with Visa - The company states: "ServiceNow ( NOW) announced a five-year strategic alliance with Visa (V), a world leader in digital payments, to transform payment services. The initial phase includes the launch of ServiceNow Disputes Management, Built with Visa-a single, connected disputes resolution solution for issuers. Managing disputes currently involves multiple systems and teams, and many financial institutions often use siloed solutions that are not fully integrated with one another. This disconnected approach creates complexity, delays crediting and resolving disputes, can create potential losses, and ultimately, impacts the customer experience. ServiceNow Disputes Management, Built with Visa is a streamlined solution that blends the best of ServiceNow's AI-first platform and the company's Financial Services Operations solution with Visa's deep technology investments. Each year, Visa helps prevent $30 billion in fraud for consumers and small businesses using cutting edge technology, including tokenization and AI, deployed throughout the entire payments ecosystem, including disputes management."
|
TSLA | Hot Stocks16:09 EST Tesla sees Cybertruck production and deliveries to ramp throughout this year - Tesla said: While we continue to execute on innovations to reduce the cost of manufacturing and operations, over time, we expect our hardware-related profits to be accompanied by an acceleration of AI, software and fleet-based profits. Cybertruck production and deliveries will ramp throughout this year. In addition, we continue to make progress on our next generation platform."
|
TSLA | Hot Stocks16:08 EST Tesla says vehicle volume growth rate 'may be notably lower' in 2024 than 2023 - Tesla said in its quarterly letter to investors: "Our company is currently between two major growth waves: the first one began with the global expansion of the Model 3/Y platform and the next one we believe will be initiated by the global expansion of the next-generation vehicle platform. In 2024, our vehicle volume growth rate may be notably lower than the growth rate achieved in 2023, as our teams work on the launch of the next-generation vehicle at Gigafactory Texas. In 2024, the growth rate of deployments and revenue in our Energy Storage business should outpace the Automotive business. We have sufficient liquidity to fund our product roadmap, long-term capacity expansion plans and other expenses. Furthermore, we will manage the business such that we maintain a strong balance sheet during this uncertain period."
|
LVS | Hot Stocks16:07 EST Las Vegas Sands CEO 'extremely pleased' with Q4 results - "We were extremely pleased with our financial and operating results for the quarter, which reflect the ongoing improvement in the operating environment in both Macao and Singapore. We remain deeply enthusiastic about our opportunities for growth in both Macao and Singapore in the years ahead," said Robert G. Goldstein, chairman and chief executive officer. "In Macao, the ongoing recovery across all segments continued during the quarter. Our decades-long commitment to making investments that enhance the business and leisure tourism appeal of Macao and support its development as a world center of business and leisure tourism positions us well as the ongoing recovery in travel and tourism spend progresses. "In Singapore, Marina Bay Sands once again delivered outstanding levels of financial and operating performance. Our new suite product and elevated service offerings position us well as airlift capacity continues to improve and the recovery in travel and tourism spending from China and the wider region continues to advance. "We are fortunate that our financial strength supports our ongoing investment and capital expenditure programs in both Macao and Singapore, our pursuit of growth opportunities in new markets, and the return of capital to stockholders. "We repurchased $505 million LVS shares under our share repurchase program during the quarter. We look forward to utilizing our share repurchase program to return excess capital to stockholders in the future. In addition, we entered into an agreement during the quarter to purchase approximately $250 million of Sands China stock, which, upon settlement of the agreement, is expected to increase our ownership interest in Sands China."
|
TSLA | Hot Stocks16:07 EST Tesla recorded one-time non-cash tax benefit of $5.9B in Q4 - Tesla said: "While it did not impact Operating Income, we did record a one-time non-cash tax benefit of $5.9B in Q4 for the release of valuation allowance on certain deferred tax assets. Cash Quarter-end cash, cash equivalents and investments increased sequentially by $3.0B to $29.1B in Q4, driven by free cash flow of $2.1B and financing activities of $0.9B."
|
FMAO | Hot Stocks16:05 EST F&M Bank announces retirements of Rex Rice Chiel Lending Officer and CAO Rupp - F&M Bank announced the retirements of Rex Rice, EVP & Chief Lending Officer and Benet Rupp, EVP & Chief Administrative Officer. Rice will remain in his role until March 1 Rupp will remain in her role until March 22, 2024. F&M also announced several promotions as part of the Company's established succession plan. Lars Eller, President and CEO, stated, "On behalf of everyone at F&M, we want to thank Rex and Benet for their years of dedication and service. Rex began with the bank in 1981 and has served in a variety of leadership capacities. He has been an integral part of F&M's success over the past 43 years, where we have seen our lending portfolio grow to over $2.5 billion. Rex has been a trusted advisor and invaluable partner, and I wish him all the best in his well-deserved retirement. Benet joined F&M in 2019 and has been an instrumental member of our executive team over the past five years. Under Benet's leadership we have continuously improved significant functions within the bank including human resources, operations, and strategic planning. I'd like to thank Benet for being a catalyst for change within the organization and I wish her all the best in her retirement."
|
RBCAA | Hot Stocks16:01 EST Republic Bancorp raises quarterly dividend 9% to 40.7c per share - The dividend will be payable April 19, 2024, to shareholders of record as of March 15, 2024.
|
INGN | Hot Stocks16:01 EST Inogen names Michael Bourque CFO - Inogen announced the appointment of Michael Bourque as Chief Financial Officer, effective March 4, 2024. Mr. Bourque has served as Treasurer and Chief Financial Officer of Chase Corporation now owned by KKR & Co. Inc. He succeeds Interim Chief Financial Officer Mike Sergesketter, who will remain in an advisory role during the transition. Mr. Bourque has served as Chief Financial Officer and Treasurer of Chase Corporation since 2021. He also served as Chief Financial Officer of Keystone Dental, Senior Vice President, Chief Financial Officer and Treasurer of Analogic Corporation from 2014 to 2018 and as Vice President of Finance for Axcelis Technologies from 2011 to 2014. Bourque received a bachelor's degree in accounting from Bentley University. Kevin Smith, President and Chief Executive Officer of Inogen said, "I am incredibly excited to announce Michael as the new Chief Financial Officer of Inogen. His experience building best-in-class finance teams at Chase, Keystone and Analogic display what makes him uniquely qualified to help Inogen continue to deliver superior respiratory solutions to patients around the world." Mr. Smith continued, "I would also like to thank Mike Sergesketter for once again stepping into the role of CFO during our search. His experience and stewardship helped ensure a smooth transition during the beginning of my tenure and the previous six months. He's been a tremendous contributor and I wish him the best in his retirement."
|
YUM | Hot Stocks16:00 EST Yum! Brands raises quarterly dividend 11% to 67c per share - The dividend will be distributed March 8, 2024 to shareholders of record at the close of business on February 21, 2024.
|
JNJ | Hot Stocks15:13 EST J&J to pay $149.5M to Washington state over role in opioid epidemic - To avoid trial in Washington Attorney General Bob Ferguson's lawsuit, opioid manufacturer and raw material supplier Johnson & Johnson will pay $149.5M to Washington state over its role fueling the opioid epidemic. Today's resolution, filed in King County Superior Court, provides Washington and its local governments with tens of millions of dollars more to combat the fentanyl epidemic compared to the settlement that Ferguson rejected in 2021. Washington is one of three states receiving more than they would have under the 2021 multistate settlement. Today's $149.5M resolution will be paid in one lump sum this fiscal year. The settlement requires that $123.3M be used to combat the opioid epidemic, including the fentanyl crisis that is devastating Washington communities. Ferguson is directing 50% of these resources to local governments across the state to combat the epidemic in their communities. In contrast, the rejected settlement promised $98.9M for Washington and its local governments to address the epidemic, which would have been paid out over a nine year term. The Washington Attorney General's Office has recovered more than $1.2B for Washington to address the fentanyl and opioid crisis.
|
GRMN | Hot Stocks15:05 EST Kawasaki Motors selects Garmin for all-new RIDGE side x sides - Garmin announced that it has been selected by Kawasaki Motors to provide a customized, factory-installed solution for the center console of the all-new 2024 Kawasaki RIDGE Limited side x sides. Incorporating Garmin technology seen in the popular Tread navigator series, this display will help guide the adventure by providing seamless navigation and vehicle systems information, such as engine data, alerts, rider settings and more. The device is also built to withstand the rigors of an off-road adventure. The display units feature a glove-friendly, 8" ultrabright display with turn-by-turn trail navigation1 that includes OpenStreetMap (OSM) and USFS Motor Vehicle Use Maps for traversing unpaved roads and trails. It comes preloaded with topographic maps, U.S. public and private landowner information and satellite Imagery. Adventure-seekers can also track and keep in touch with friends on the trail through Group Ride Radio features. The integrated displays also provide vehicle information such as RPM, engine temperature, battery voltage, CVT temperature and more.
|
BRKL | Hot Stocks14:53 EST Brookline Bancorp Chief Operations Officer James Cosman to retire - Brookline Bancorp Co-President and Chief Operating Officer Michael McCurdy announced three key changes affecting leadership positions at Brookline Bancorp. After fifteen years as the company's Chief Operations Officer, James Cosman will retire effective April 1. Cosman will remain with the company on a part-time basis and work on special projects. Mona Macero, currently Senior Vice President, Managing Director of the Commercial Markets Payment Group at the company, will assume the role of Executive Vice President and Chief Digital Officer upon Cosman's retirement. Kelly Bressette, currently Director of Loan Operations, will become Executive Vice President, Director of Operations, overseeing Loan and Deposit Operations and Mortgage Underwriting. Bressette will report directly to McCurdy.
|
JACK | Hot Stocks14:43 EST Jack in the Box sees restaurant level margin reaching 23%-25% by 2027 - Jack in the Box executives stated during the company's investor day meeting, according to a transcript of the event: "We provided our guidance several months ago for fiscal 24, which you see on the slide. We want to also give you a marker between what we think is a very reasonable and achievable target for us by 2027... You know, the last several years have probably been impacted by inflation and supply chain issues, and we're still feeling some effects in our fiscal 24, along with our friends in California making some legislative changes. But as we roll forward in the next several years, we think it's very realistic for this business to have a consistent, sustainable 2 to 3% same store sales growth. You couple that with the new unit growth expectations we've got. We think we can drive really strong systemwide sales growth... You see our restaurant level margin guidance for 2024. We know there's more we can do. And so if you look to 27, we can get we think we can get to 23 to 25% on the side. That gets us very close to our ambition. Del Taco has more opportunity, but they also those opportunities are going to execute against them and we expect to get those margins continue to increase over the years... Again, we talked about this a couple of weeks ago at the ICR conference. I just want to reiterate again, our strategy towards getting to an asset light model for Del Taco there. I mentioned earlier we've already gone from 50 to 70% refranchising, 111 of our nearly 600 restaurants last year. And we have conviction and clarity on how we can move to a plus 90% franchised model by the end of the fiscal 26. We got very interested partners, both existing and new, that want to have access to this incredible iconic brand."
|
MULN | Hot Stocks14:02 EST Mullen Automotive regains compliance with Nasdaq minimum bid price requirement - Mullen Automotive announces that it has received formal notice from The Nasdaq Stock Market LLC confirming the company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). Mullen will continue to be listed and traded on The Nasdaq Capital Market.
|
VZ... | Hot Stocks14:01 EST Verizon announces new streaming bundle featuring Netflix and STARZ - Verizon (VZ) announced that starting today customers can get Netflix Premium (NFLX) and STARZ (LGF.A) together for $25.99 per month. "This is the first time the two streaming services have been offered together, and the savings are only for Verizon customers," the communications company stated.
|
CNI... | Hot Stocks13:50 EST North American rail traffic down 13.5% for the week ending January 20 - The Association of American Railroads or AAR, reported U.S. rail traffic for the week ending January 20. For this week, total U.S. weekly rail traffic was 397,553 carloads and intermodal units, down 13.2% compared with the same week last year. Total carloads for the week ending January 20 were 173,371 carloads, down 22.4% compared with the same week in 2023, while U.S. weekly intermodal volume was 224,182 containers and trailers, down 4.5% compared to 2023. None of the 10 carload commodity groups posted an increase compared with the same week in 2023. Commodity groups that posted decreases compared with the same week in 2023 included coal, down 21,055 carloads, to 47,731; nonmetallic minerals, down 11,953 carloads, to 18,628; and grain, down 5,246 carloads, to 15,752. North American rail volume for the week ending January 20, on 12 reporting U.S., Canadian and Mexican railroads totaled 265,838 carloads, down 20.3% compared with the same week last year, and 289,982 intermodal units, down 6.0% compared with last year. Total combined weekly rail traffic in North America was 555,820 carloads and intermodal units, down 13.5%. North American rail volume for the first three weeks of 2024 was 1,778,528 carloads and intermodal units, down 5.6% compared with 2023. Publicly traded companies in the space include CSX (CSX), Canadian National (CNI), Canadian Pacific Kansas City (CP), Kansas City Southern (KSU), Norfolk Southern (NSC), Union Pacific (UNP), , Trinity Industries (TRN), Greenbrier (GBX), FreightCar America (RAIL), Rail Vision (RVSN) and Wabtec (WAB). Reference Link
|
YOU | Hot Stocks12:41 EST Clear Secure higher after TSA PreCheck online renewals goes live - Shares of Clear Secure are moving higher after Needham analyst Joshua Reilly pointed out the TSA PreCheck for renewal customers online has gone live today. This means is customers who visit the TSA PreCheck website put on by the TSA.GOV will now have the opportunity to click a link and renew their PreCheck through Clear Secure, and also optionally be able to purchase a bundle of PreCheck plus Clear Plus for $190.95, the analyst told investors in a research note. This implies a first year price of $122.00 for Clear Plus and the five-year renewal membership of PreCheck of $68.95, according to Needham. The firm, which notes customers can still not sign-up net new for PreCheck online or in the airport, believes "this first step indicates an in airport offering for both renewals and net-new customers is approaching." Needham thinks bundle pricing should accelerate Clear Secure's net member additions in Q1. The stock in afternoon trading is up 4% to $19.83.
|
HARL | Hot Stocks12:27 EST Harleysville Financial announces 3.3% increase of quarterly dividend to 31c - Harleysville Financial announced that the company's Board of Directors declared a regular quarterly cash dividend of 31c per share on the company's common stock. This represents an increase of 3.3% or 1c per share from the previous dividend. The cash dividend will be payable on February 21, 2024 to stockholders of record on February 7, 2024.
|
TXT | Hot Stocks12:00 EST Textron rises 8.3% - Textron is up 8.3%, or $6.58 to $85.91.
|
BHG | Hot Stocks12:00 EST Bright Health rises 10.9% - Bright Health is up 10.9%, or $1.45 to $14.70.
|
UNG | Hot Stocks12:00 EST United States Natural Gas Fund rises 311.3% - United States Natural Gas Fund is up 311.3%, or $15.66 to $20.69.
|
SAVE | Hot Stocks12:00 EST Spirit Airlines falls -8.3% - Spirit Airlines is down -8.3%, or -67c to $7.46.
|
DD | Hot Stocks12:00 EST DuPont falls -11.5% - DuPont is down -11.5%, or -$8.56 to $66.13.
|
ANVS | Hot Stocks12:00 EST Annovis Bio falls -16.3% - Annovis Bio is down -16.3%, or -$1.90 to $9.74.
|
DTST | Hot Stocks11:48 EST Data Storage expands contract with global telecommunications company - Data Storage Corporation announced that it has secured a six-figure contract with a multinational telecommunications company to replace and maintain its old tape library with new advanced backup technology. The company has had an established relationship with this multinational corporation for over a decade and this new contract expands on the current solutions provided by Data Storage Corporation."We are proud to have maintained a long-term successful relationship with this multinational corporation for over twelve years," commented Thomas Kempster, CEO of Flagship.
|
ACN | Hot Stocks11:31 EST Accenture and Mujin announce joint venture around AI and robotics - Accenture and Mujin announce they have established Accenture Alpha Automation, a joint venture for the manufacturing and logistics industries. "Accenture Alpha Automation will help companies automate their management infrastructure with data-driven solutions that seamlessly combine data from manufacturing and logistics operations with management data. The joint venture is owned 70% by Accenture and 30% by Mujin... Accenture has also invested directly in Mujin through Accenture Ventures, marking its first Project Spotlight investment in Asia. Project Spotlight is an engagement and investment program focused on companies that create or apply disruptive enterprise technologies. The program offers extensive access to Accenture's domain expertise and its enterprise clients, helping technology companies adapt their solutions to the enterprise market and scale faster and more effectively," the companies stated.
|
BOX | Hot Stocks11:08 EST Box acquires Crooze, terms not disclosed - Box has acquired Crooze, a leading provider of no-code enterprise content management applications built on the Box Platform. Box will leverage Crooze's team and technology -- including the company's no-code app builder and metadata capabilities -- to help organizations address business-critical processes like contract lifecycle management, digital asset management, controlled document management, enterprise content libraries, and more. Crooze provides a broad range of capabilities to help customers get the most out of their content in Box: A no-code builder for critical business-document applications. An extensive set of metadata tools to greatly simplify all aspects of metadata, including adding, analyzing and managing it at scale. Customized dashboards and views of underlying Box content and metadata. Forms and document generation capabilities. Ability to integrate with Box Relay to automate content workflows. Crooze's capabilities enable customers to easily and quickly build apps to manage critical content on Box, including contracts, digital assets, and controlled documents: Contract management: Organizations can digitally transform their legal contracts repository and processes with the ability to generate documents on-demand, streamline e-signatures with Box Sign, and automate processes with Box Relay for efficient handling of contracts. Digital asset management: Marketing teams can organize, manage, share and distribute assets, automate processes through Box Relay to manage end-to-end asset lifecycles, deliver curated assets internally and externally, and streamline metadata management with robust tools for enhanced productivity. Controlled document management: Departments can establish a secure document library on Box for controlled documents like corporate records, HR policies, and financial records, leverage Box Shield for document protection, enforce retention policies with Box Governance, manage metadata at scale by applying, editing, and searching across thousands of files, and automate processes seamlessly with Box Relay for review and approval protocols. Box will continue to offer and support Crooze products and services, and in parallel will integrate the Crooze technology natively into the Box Content Cloud. Customers interested in learning more about how to leverage Crooze offerings today should contact their Box account team. Box expects to announce availability and pricing for new capabilities based on Crooze later this year.
|
SNOW CRM | Hot Stocks11:02 EST Snowflake names Brad Burns as chief communications officer - Snowflake (SNOW) announced that Brad Burns is joining the company as Chief Communications Officer. In his new role, Burns will be responsible for Snowflake's communications strategy. Burns joins Snowflake from Salesforce (CRM) where he was Chief Communications Officer.
|
RR | Hot Stocks10:56 EST Richtech Robotics Inc trading resumes
|
GWAV | Hot Stocks10:48 EST Greenwave Technology receives license from Ohio Bureau of Motor Services - Greenwave Technology Solutions announced that its wholly-owned subsidiary, Empire Metals, is now licensed to purchase end-of-life vehicle in the State of Ohio. Scrapping end-of-life vehicles is a core revenue and profit generator for Greenwave, contributing more than $5 million to the Company's top line in FY 2023. Greenwave's scrap car buying platform, ScrapApp.com, continues to rapidly scale in the Hampton Roads, VA and Cleveland, OH markets. The Company expects to expand Scrap App to additional strategic markets in February 2024 and believes Scrap App has the potential to scale significantly, with a competitor reportedly generating $159 million in annual revenue.
|
RR | Hot Stocks10:46 EST Richtech Robotics Inc trading halted, volatility trading pause
|
FCX | Hot Stocks10:14 EST Freeport-McMoRan: Copper inventories at historically low levels
|
FCX | Hot Stocks10:14 EST Freeport-McMoRan: Copper prices reflective of macro factors vs. available supply
|
FCX | Hot Stocks10:06 EST Freeport-McMoRan: Continues to be 'micro vs. macro' story - When macro outlook improves, Freeport-McMoRan says "watch out for copper price." Comments taken from Q4 earnings conference call.
|
SGH | Hot Stocks10:02 EST Cree LED, Current Lighting enter license agreement - Cree LED and Current Lighting Solutions announced that they entered into a patent license agreement, effective October 2022, with respect to Current's patents related to KSF red phosphor. Under the agreement, Cree LED has been granted by Current, a limited, nonexclusive, and world-wide license under U.S. Patent Nos. 7,358,542; 7,453,195; 7,497,973; 7,648,649; 7,847,309; and 9,680,067. This license covers Cree LED products featuring Pro9 technology which utilizes Potassium Fluoride Silicon. This phosphor boosts the efficiency of LED components, especially those delivering higher CRI.
|
INTC | Hot Stocks10:01 EST Intel opens Fab 9 in New Mexico - Intel celebrated the opening of Fab 9, its cutting-edge factory in Rio Rancho, New Mexico. The milestone is part of Intel's previously announced $3.5B investment to equip its New Mexico operations for the manufacturing of advanced semiconductor packaging technologies, including Intel's breakthrough 3D packaging technology, Foveros, which offers flexible options for combining multiple chips that are optimized for power, performance and cost.
|
ALUR | Hot Stocks10:00 EST Allurion Technologies rises 7.8% - Allurion Technologies is up 7.8%, or 24c to $3.32.
|
TAL | Hot Stocks10:00 EST TAL Education rises 10.6% - TAL Education is up 10.6%, or $1.16 to $12.04.
|
UNG | Hot Stocks10:00 EST United States Natural Gas Fund rises 308.2% - United States Natural Gas Fund is up 308.2%, or $15.50 to $20.53.
|
BB | Hot Stocks10:00 EST BlackBerry falls -11.3% - BlackBerry is down -11.3%, or -40c to $3.15.
|
DD | Hot Stocks10:00 EST DuPont falls -13.3% - DuPont is down -13.3%, or -$9.94 to $64.75.
|
ANVS | Hot Stocks10:00 EST Annovis Bio falls -14.1% - Annovis Bio is down -14.1%, or -$1.64 to $10.00.
|
ABT | Hot Stocks09:52 EST Abbott says 'probably more upside than downside' to FY24 EPS guidance - Says gross margin expansion is a "high priority." Says robust pipeline will sustain growth through 2025 and beyond. Expects to launch nutritional drink for GLP-1 users this year. Says will be "selective" with M&A as company's strong pipeline should provide organic revenue growth.
|
ALUR | Hot Stocks09:47 EST Allurion Technologies rises 12.0% - Allurion Technologies is up 12.0%, or 37c to $3.45.
|
TAL | Hot Stocks09:47 EST TAL Education rises 13.7% - TAL Education is up 13.7%, or $1.49 to $12.38.
|
UNG | Hot Stocks09:47 EST United States Natural Gas Fund rises 311.3% - United States Natural Gas Fund is up 311.3%, or $15.66 to $20.69.
|
BB | Hot Stocks09:47 EST BlackBerry falls -9.9% - BlackBerry is down -9.9%, or -35c to $3.20.
|
ANVS | Hot Stocks09:47 EST Annovis Bio falls -10.2% - Annovis Bio is down -10.2%, or -$1.19 to $10.46.
|
DD | Hot Stocks09:47 EST DuPont falls -12.8% - DuPont is down -12.8%, or -$9.54 to $65.14.
|
FRSX RVSN | Hot Stocks09:28 EST Foresight Autonomous says Rail Vision receives order up to $5M - Foresight Autonomous Holdings announced that its affiliate, Rail Vision has signed a supply contract with a leading US-based rail and leasing services company valued at up to $5 million for the purchase of Rail Vision's artificial intelligence-based Switch Yard Systems. Foresight owns 10.2% of Rail Vision's outstanding share capital.
|
F | Hot Stocks09:26 EST Ford recalls nearly 1.9M 2011-2019 Explorer SUVs in the U.S. - Ford is recalling nearly 1.9 million Explorer SUVs in the U.S. because a trim piece can fly off and create a hazard for other drivers, according to a recall notice posted by the U.S. NHTSA. The recall covers Explorers from the 2011 through 2019 model years. The company is aware of 568 consumer complaints and more than 14,000 warranty reports alleging that the parts were missing or detached. Ford said it is not aware of any crashes or injuries from the problem.
|
MA | Hot Stocks09:25 EST MasterCard and The Clearing House extend multi-year partnership - Mastercard and The Clearing House have announced an extended multi-year partnership, bringing the companies together to collaborate on innovative capabilities for consumers, businesses and governments to evolve and embrace the digital economy through real-time payments adoption on the RTP network. The partnership continues Mastercard's role as the exclusive instant payments software provider for TCH's RTP network, enabling both companies to integrate new instant payment use cases across a range of payment flows. Instant payments became a reality in the U.S. in 2017 when The Clearing House launched the RTP network, the first new payment rail in 40 years designed and powered by Mastercard. For consumers, RTP provides instant access and confidence that a payment is received, 24/7. For businesses, RTP enhances value by simplifying payments for customers, enabling faster wage disbursements, improving liquidity management, and optimizing capital workflows, and for governments, it helps activate local economies through disbursement and settlement.
|
PTPI | Hot Stocks09:21 EST Petros Pharmaceuticals announces two upcoming FDA meetings on STENDRA - Petros Pharmaceuticals has scheduled two meetings with the U.S. Food and Drug Administration to review the Company's progress and path forward in developing STENDRA as the first PDE-5 inhibitor approved as an over-the-counter medication for erectile dysfunction. The Company has scheduled a Type C meeting with the FDA on March 26, 2024, to review the Company's developing digital app for use under the FDA's Nonprescription Drug Product with an Additional Condition for Nonprescription Use proposed rule. Primary topics of the meeting are expected to include how to continue the development of the app, protocols for upcoming studies, including the Summative Human Factors Study. In addition, the FDA has requested a listen-only meeting during the week of March 11th to review the app for improved productivity during the Type C meeting.
|
EFSH | Hot Stocks09:20 EST 1847 Holdings secures $750,000 credit facility - 1847 Holdings has secured a $750,000 credit facility for its Wolo Manufacturing Corp. subsidiary. Wolo is a leading manufacturer and distributor of vehicle horns and safety products and offers vehicle emergency and safety warning lights for cars, trucks, industrial equipment and emergency vehicles.
|
FNGR | Hot Stocks09:19 EST FingerMotion announces preliminary director approval of dividend warrant - FingerMotion announces that the Company's Board of Directors has preliminarily approved a dividend in kind of warrants to purchase shares of the Company's common stock to holders of the Company's common stock . The terms of the Dividend Warrants, and the record and payment dates for the Dividend, will be fixed by further resolution of the Board of Directors. The Dividend Warrants are anticipated to be created and allotted pursuant to a warrant agreement to be entered into between FingerMotion and a suitably qualified institutional warrant agent. The Company intends to file a registration statement on Form S-3 with the United States Securities and Exchange Commission for the purpose of registering the Dividend Warrants and the underlying Common Shares under the United States Securities Act of 1933, as amended and to apply to The Nasdaq Stock Market LLC for the listing of the Dividend Warrants and the underlying Common Shares on the Nasdaq Capital Market. The declaration of the Dividend is expected to take place after the SEC completes its review process, subject to market and other conditions.
|
NEPT | Hot Stocks09:18 EST Neptune Wellness to explore strategic alternatives for Sprout Organics - Neptune Wellness announced the appointment of Stifel Nicolaus Canada to act as exclusive financial advisor to the Company's organic baby food and toddler brand, Sprout Foods, providing financial advisory, investment banking services, and strategic advice regarding the review of divestiture alternatives related to Sprout Organics. The Company initially communicated plans for a spinoff of Sprout Organics, but due to changing circumstances, leadership is working with Stifel actively to assess alternative strategies. Under the terms of the collaboration, Sprout Organics, Neptune and Stifel will work to evaluate available strategic options to unlock and maximize shareholder value.
|
CAPR | Hot Stocks09:17 EST Capricor Therapeutics, NIH collaborate for trial of StealthX vaccine - Capricor Therapeutics announced that Capricor's proprietary StealthX exosome-based multivalent vaccine for the prevention of SARS-CoV-2 has been selected to be part of Project NextGen, an initiative by the U.S. Department of Health and Human Services to advance a pipeline of new, innovative vaccines providing broader and more durable protection for COVID-19. As part of Project NextGen, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, will conduct a Phase 1 clinical study with Capricor's StealthX vaccine, subject to regulatory approval. NIAID's Division of Microbiology and Infectious Diseases would oversee the study.
|
ABT | Hot Stocks09:16 EST Abbott says investments in R&D paying off, pipeline strong - Comments taken from Q4 earnings conference call.
|
FCX | Hot Stocks09:15 EST Freeport-McMoRan sees FY24 copper sales 4.1B lbs, gold 2M ozs - Freeport-McMoRan, in slides being presented on its Q4 earnings conference call, said progress for its Indonesia smelter projects exceeded 90% at year end. Near-term fundamentals for copper significantly improved in late 2023, Freeport said, adding that the copper price outlook is "increasingly positive." Sees FY24 molybdenum sales 85M lbs. Sees FY24 CapEx $3.6B excluding smelter projects. Sees Q1 copper sales 1M lb, Q2 copper sales 1M lb, Q3 copper sales 1.03M lbs, and Q4 copper sales 1.06M lbs.
|
AIMD | Hot Stocks09:15 EST Ainos announces $1.75M follow-on funding - Ainos has placed an additional financing with Lind Global Fund II LP, an institutional investment fund managed by The Lind Partners. The funding amount is up to $1.75 million, with $875,000 funded at closing and $875,000 to be funded subject to effective registration statement and conditions specified in the agreement. The increased funding is in the form of amendment to a Senior Secured Convertible Promissory Note maturing on March 28, 2025, with extension option specified in the agreement. The Note will be convertible into Ainos' shares of common stock at an initial conversion price equal to $7.50 per share, reverse-split adjusted, and subject to adjustment as further specified in the Note. The Note will be repayable in cash upon maturity. Prior to maturity, the Investor can convert to common stock at conditions specified in the agreement. As part of the investment, the Investor was also granted five-year warrants equal to 75% of the funded amount at an initial exercise price equal to $2.16 per share of common stock, subject to adjustment. Maxim Group LLC is acting as the lead placement agent for the private placement. Brookline Capital Markets, a division of Arcadia Securities, LLC is acting as the co-placement agent for the private placement.
|
HWH | Hot Stocks09:14 EST HWH International sees 'prosperous year' in 2024 - HWH International offered an update on HWH's business operations since the completion of the business combination on January 9, 2024. The company said, "As a public company listed on Nasdaq, we are confident that this milestone will significantly bolster the credibility and confidence in our business, laying a robust foundation as we navigate towards a prosperous year in 2024. HWH's food and beverage division, particularly the successful launch of the "Hapi Cafe" brand, has begun to reach stability and is enhancing its offerings to boost sales. With Hapi Cafe branded outlets across Asia, including Singapore, the Republic of China, Hong Kong, the People's Republic of China, and South Korea, Hapi Cafe is positioned to be an integral part of HWH's business model. HWH, as the proud owner of Hapi Cafe stores in Singapore and South Korea, aims to aggressively expand its presence, fostering community connections and expanding HWH's unique offerings. Building on these achievements, HWH is gearing up for the launch of membership sales. HWH will offer innovative promotions to introduce the group's products and services and reward valued customers with exclusive benefits, including loyalty discounts. In alignment with HWH's dedication to healthier meal options, HWH continues to actively seek collaborations with original equipment manufacturers for nutritious meal prep services in other countries. Leveraging the expertise of KetoMei, an associated company and one of the largest Keto meal prep providers in Singapore, HWH aims to cater to the diverse preferences of its members."
|
AIM | Hot Stocks09:12 EST AIM ImmunoTech receives Erasmus MC Ethics Board authorization - AIM ImmunoTech has received authorization from the Erasmus Medical Center Ethics Committee to open a European site for the ongoing Phase 2 study ("AMP-270") of Ampligen as a therapy for locally advanced pancreatic cancer. AMP-270 is a randomized, open-label, controlled, parallel-arm clinical trial with the primary objective of comparing the efficacy of Ampligen versus a no treatment control group following FOLFIRINOX for subjects with locally advanced pancreatic adenocarcinoma. Secondary objectives include comparing safety and tolerability. AMP-270 is expected to enroll approximately 90 subjects in the United States and Europe.
|
BTCS | Hot Stocks09:09 EST BTCS reports fair value of crypto, cash at $26.7M as of Dec. 31 - The company said, "Our strategic decisions paid off as we ended the year with considerable momentum. As of December 31, 2023, the Fair Market Value of our cryptocurrency and cash rose 82% year over year to an impressive $26.7M. This significant increase is not just a number - it symbolizes the trust you place in us to navigate volatile markets and protect our assets. Additionally, the recent rise in the FMV of our crypto assets, positions us to enhance revenue in 2024, reinforcing our financial health and growth trajectory."
|
GEVO | Hot Stocks09:09 EST Gevo provides business update - Gevo provided a business update. Gevo also expects to publish an updated corporate investor presentation to its website. RNG: Non-GAAP cash EBITDA of $7-16 million is expected in 2024, depending upon the timing of the approval of the permanent CARB Carbon Intensity pathway . Net-Zero 1 Development: Net-Zero 1 is in the diligence phase of the US Department of Energy Loan Guarantee Program to secure construction funding. The engineering for the project is substantially complete and is in the value engineering phase in preparation for finalizing the fully installed contracted price. Verity expects to announce its first revenue in 2024 and to pursue scalable customer growth in 2025. Based on a market and business analysis by a well known global consulting firm, the initial target market for Verity is estimated to be $1.5-3 billion in the United States. 2024 Expected Uses of Cash: Discretionary Project Development and Growth Uses of Cash: The company said, "We believe we have significant flexibility over the timing and amount of our discretionary growth spending related to our projects. The majority of Gevo's expected uses of cash in 2024 from discretionary growth spending is related to the development of growth projects, primarily driven by Net-Zero 1." Net-Zero 1 Project Development: Uses of cash are projected to be $125-175 million in 2024. NZ and Other Projects Development: Expected uses of cash of $20-60 million in 2024. Research & Development: Expected uses of cash of $10-12 million in 2024, which includes feasibility and scaleup of our ETO technology as well as improvements on isobutanol fermentation and other R&D
|
MAR | Hot Stocks09:07 EST Marriott announes expansion of Apartments by Marriott Bonvoy portfolio - Marriott plans to further expand its new Apartments by Marriott Bonvoy brand offering, with signed development agreements in Detroit and St. Louis in the U.S., Courmayeur, Valle D'aosta in Italy, and NEOM, Saudi Arabia. In Detroit, Michigan, the property anticipated to open in Q3 is a conversion of The Plaza Apartments in Midtown Detroit, centrally located in the hub of the city. A new project with Midas Hospitality, owner and operator of Marriott properties, for an Apartments by Marriott Bonvoy in St. Louis, Missouri, will be co-located with a new Sheraton Hotel in downtown St. Louis. In Courmayeur, Aosta Valley, Italy, Marriott signed an agreement with Castello Sgr, an asset management company, to open Le Geant, an Apartments by Marriott Bonvoy property anticipated to have 47 units. Marriott also signed an agreement with NEOM to bring Apartments by Marriott Bonvoy to the luxury island destination Sindalah on the northwest coast of Saudi Arabia, a luxury island destination in the Red Sea anticipated to open in 2024 and featuring 218 units.
|
STLA | Hot Stocks09:05 EST Stellantis announces acquisition of CloudMade's AI technologies, IP - Stellantis N.V. announced the acquisition of the artificial intelligence, AI, framework, machine learning models and intellectual property, IP, rights and patents of CloudMade, a developer of smart and innovative big data-driven automotive solutions. The acquisition - as an asset deal - will support the mid-term development of STLA SmartCockpit and reinforces Stellantis' software strategy outlined in Dare Forward 2030. "The acquisition of CloudMade's pioneering AI capabilities will accelerate our development journey on STLA SmartCockpit and help us deliver our Dare Forward 2030 goals," said Yves Bonnefont, Stellantis Chief Software Officer. "Thanks to this adaptable technology and leveraging our growing connected car parc, we will create intelligent mobility solutions faster and with more flexibility, to delight our customers with in-vehicle and mobile experience personalization."
|
BTCS | Hot Stocks09:05 EST BTCS CEO 'enthusiastic' about opportunities that lie ahead - BTCS issued a letter to its shareholders describing the Company's recent achievements and goals for 2024. The letter from Charles Allen, CEO of BTCS, read in part, "Looking ahead to 2024, the landscape of cryptocurrency continues to evolve rapidly. The introduction of Bitcoin ETFs marked a significant milestone and we anticipate the launch of an Ethereum ETF, although the timing is uncertain, which we believe will further catalyze market acceptance and growth. This development aligns perfectly with our strategic focus on Ethereum-based solutions and infrastructure. Innovations and Future Plans In our product development, which has been a core focus of our efforts over the last year, we are excited about the future launch of the following products: Builder+, a significant enhancement to our Ethereum blockchain infrastructure, is our newly developed Ethereum block builder, which utilizes advanced algorithms to meticulously construct optimized blocks for on-chain validation designed to maximize validator earnings. We believe Builder+ should provide a path to scalable revenue on Ethereum's blockchain with limited additional costs. ChainQ, is an under-development AI-powered blockchain data and analytics platform, designed to allow users to query real-time and historical on-chain blockchain data. Through comprehensive indexing of public blockchain data from our Blockchain Infrastructure operations, ChainQ is intended to provide an intuitive and straightforward platform for users to access on-chain data. StakeSeeker, we are exploring the feasibility of adding Ethereum non-custodial staking to our StakeSeeker platform in 2024, with the goal of further diversifying our revenue streams and focusing on expanded and scalable offerings in the cryptocurrency space. Enhancing Online Presence and Communication In line with our commitment to transparency and shareholder engagement, we plan to update our corporate website. This revamp aims to better reflect our initiatives, strategies, and the evolving nature of our business. Additionally, we plan to release a new corporate presentation designed to provide deeper insights into our operations and the exciting opportunities we foresee. These enhancements to our digital presence are part of our broader strategy to ensure open, clear, and continuous communication with you, our shareholders. Strategic Cost-Cutting Initiatives Amidst Market Challenges In most of 2023, we faced significant challenges as the industry emerged from crypto winter. In stark contrast to many of our public peers who resorted to toxic funding methods, thereby destabilizing their capital structures, we adopted a more sustainable approach. Our strategic cost-cutting initiatives, focused on operational efficiency, allowed us to weather this period without compromising our product development or our market position. This prudent approach was pivotal in maintaining our financial stability and protecting shareholder value in a volatile market. Conclusion As your CEO, I am proud of what we have accomplished in the face of adversity, and enthusiastic about the opportunities that lie ahead. Your trust and support are the backbone of our success, and we remain dedicated to delivering on our promise of innovation, growth, and sustainability in the dynamic world of cryptocurrency."
|
VRNS SNOW | Hot Stocks09:04 EST Varonis extends data security posture management coverage to Snowflake - Varonis Systems (VRNS) announced it expanded its cloud-native platform with data security posture management for Snowflake (SNOW). The latest integration broadens Varonis' extensive coverage to continuously discover and classify critical data, remove exposures, and detect threats to customers' Snowflake data warehouses and databases. "Varonis is thrilled to extend our DSPM offering once again, this time into cloud data warehouses with our integration with Snowflake," said David Bass, Varonis Executive VP of Engineering and CTO. "At Varonis, we're constantly expanding our coverage to the critical data stores that matter most to our customers, so they can rest assured knowing that Varonis is watching and securing their data no matter where it lives across the cloud."
|
MBRX | Hot Stocks09:03 EST Moleculin Biotech reports expected upcoming milestones for 2024 - Moleculin Biotech announced upcoming 2024 milestones. For Annamycin in AML, 1H 2024: in-depth data review and presentation of topline data on MB-106 clinical trial; 1H 2024: MB-106 End of Phase 2 meeting with the FDA and/or its European equivalent; mid 2024: identify next phase of development/pivotal program; late 2024 into 1H 2025: initiate pivotal program. For Annamycin in STS Lung Mets: 2H 2024: final MB-107 data readout; 2024: identify next phase of development/pivotal program; late 2024 into 1H 2025: initiate 1st line STS study with an investigator-initiated trial. Moleculin is in ongoing discussions in separate programs evaluating WP1066 for the treatment of glioblastomas and/or pediatric brain tumors and expects to finalize agreements with Northwestern University for an investigator-initiated and funded trial in early 2024. Expects to report topline results from investigator-initiated Phase 1 study in pediatric brain tumors; announce results of formulation efforts for intravenous delivery; expects commencement of investigator-initiated adult clinical trial to be announced in 1H 2024. Seeking investigator-initiated pediatric cancer clinical trial in 2H 2024. Expects to report preliminary findings of animal testing of WP1096 in the Tacaribe Arenavirus and identify investigators interested in initiating a clinical trial to study the safety, pharmacokinetics, and efficacy of oral WP1122 in adult patients with GBM.
|
MNY | Hot Stocks09:02 EST MoneyHero promotes Murthy to CBO, preannounces year-over-year growth - MoneyHero announced impressive unaudited, year-over-year growth milestones for Q4 2023, including: Approved Applications surged by over 80%, significantly outperforming competitors and driving strong revenue growth; Group revenue increased by more than 50% YoY from US$17.2m in Q4'22; and Singapore revenue, a key growth market for the Company, increased more than 100% YoY from US$6.3m in Q4'22. Additionally, MoneyHero has promoted Chief Product Officer Rohith Murthy to the role of Chief Business Officer, CBO. Rohith has been an integral part of the Company's leadership team for close to a decade, and during that time has demonstrated a proven track record of driving innovation and growth within the organization. In his new role as Chief Business Officer, Rohith will oversee product, technology, and marketing at MoneyHero, ensuring a seamless integration of these critical functions to further drive the Company's success.
|
RTX | Hot Stocks09:02 EST RTX's Raytheon awarded $154M U.S. Army - Raytheon, an RTX business, announced a $154M award to deliver Commander's Independent Viewer systems to the U.S. Army to upgrade the service's Bradley Fighting Vehicles. CIV is an electro-optical/infrared sight system utilizing second-generation forward-looking infrared cameras and sensors that provide the U.S. Army's Bradley Fighting Vehicle with 360-degree battlefield oversight and targeting capabilities. Production of the units will take place in McKinney, Texas. The first delivery is expected June 2026.
|
FICO | Hot Stocks09:02 EST FICO announces new $500M stock repurchase program - FICO announced that its board of directors has approved a stock repurchase program to acquire up to $500M of the company's outstanding common stock. This new program was approved following completion of FICO's previous stock repurchase program, which was in effect from October 2022 until adoption of the new program in January. The new stock repurchase program, which is open-ended, allows the company to repurchase its shares from time to time in the open market and in negotiated transactions.
|
SILO | Hot Stocks08:59 EST Silo Pharma says SPC-14 showed 'positive efficacy' in small animals - Silo Pharma announced that its Alzheimer's disease therapeutic SPC-14 showed positive efficacy in small animals. Data from a study conducted at Columbia University in collaboration with Silo Pharma showed that SPC-14 was effective against LH stress in attenuating learned helplessness, perseverative behavior, and hyponeophagia. The mice were treated twice daily with the SPC-14 therapeutic. "We believe that today's announcement, along with our past studies of SPC-14 conducted in female rodents, lends credibility to our discovery of a therapeutic that could bring relief to patients and families suffering from Alzheimer's disease, a debilitating disease that degrades cognitive function and can erase a lifetime of memories. We look forward to updating our shareholders on the next steps and data needed to advance SPC-14 to a clinical study," stated Eric Weisblum, CEO.
|
SJI | Hot Stocks08:59 EST SJI appoints Barbara Romano as CIO - SJI announced that Barbara Romano has been promoted to chief information officer, replacing Leonard Brinson Jr., who is retiring at the end of the month. Romano, who previously served as SJI's vice present for technology and operations, becomes the first woman to take on the CIO role at the utility holding company that provides natural gas to more than 725,000 customers in New Jersey. In her new role, Romano will provide strategic guidance, leadership, and direct oversight at the corporate level for all technology and business information system initiatives for SJI and its subsidiaries. Romano will also be responsible for advancing and sustaining the corporate infrastructure and network for new technology initiatives, ensuring the performance, integrity, and security of SJI's technology platforms.
|
MBRX | Hot Stocks08:58 EST Moleculin Biotech reports preliminary data on 2023-end annamycin clinical trials - Moleculin Biotech announced 2023 year-end Annamycin clinical trials preliminary data and 2024 expectations for multiple data readouts and a transition to pivotal Phase 2B/3 clinical studies. The company is currently conducting its Phase 1B/2 clinical trial evaluating Annamycin in combination with Cytarabine for the treatment of subjects with AML as both first line therapy and for subjects who are refractory to or relapsed after induction therapy. The company has also begun recruiting 1st line subjects into this trial. The company continues to treat subjects in the Phase 2 portion of the study. Among subjects who had an evaluable post treatment bone marrow biopsy, or who dropped out due to an adverse event, there have been 6 complete responses and 1 complete response with incomplete recovery of the intent to treat subjects and 46% CR's and 54% CR/CRi's of the subjects treated. The company does not expect the addition of a cohort to delay its End of Phase 2 Meeting with the FDA. The first CR subject was treated in February 2023. The company has not been notified of any relapses to date, indicating significant durability of the CRs. There continues to be no evidence of cardiotoxicity. Moleculin expects to complete recruitment and report topline data in 1H 2024, if not by the end of Q1. In the Phase 2 portion of its U.S. Phase 1B/2 clinical trial evaluating Annamycin as monotherapy for the treatment of soft tissue sarcoma lung metastases, preliminary data from the Phase 1B portion of the study showed median PFS for 67% of the Phase 1B subjects of over 2 months and median overall survival of 11.3 months. Phase 1B subjects with less than or equal to 2 prior treatments and treated at the recommended Phase 2 dose or lower demonstrated a higher percentage of subjects with PFS of 2 months or greater at 78%. The company believes that the data will be similar to or better than the Phase 1B portion of the study.
|
ARHS | Hot Stocks08:57 EST Arhaus unveils Spring 2024 Collection - Arhaus debuts its Spring 2024 Collection, 'A Story Unfolding.' Presenting luxurious Italian upholstery introductions and collection expansions, a relaunch of its bedding assortment, and a celebration of materials, time-honored techniques, and artisan roots, 'A Story Unfolding' treasures the memories of home while inspiring those to come. The complete Spring 2024 Collection is now available online at Arhaus.com and in more than 90 Arhaus showrooms nationwide.
|
LEXX | Hot Stocks08:54 EST Lexaria Bioscience says 'never been more confident' in IP portfolio - Lexaria Bioscience provided an annual letter from CEO Chris Bunka as a strategic update to all stakeholders, which read in part, "2023 was an "interesting" year: we successfully completed a number of important research projects and we were awarded more new patents than during any other year in our history. We had no choice but to raise capital and were severely punished because of it. That said, we have since received roughly $800,000 from the exercise of warrants associated with that financing, and the additional working capital is welcome. Our revenue generation is a welcome additional to our income statement but remains mostly insignificant and irrelevant to our much more ambitious goals of seeing DehydraTECH actively in use by a "Fortune-500"-type company. Late in 2023 we discovered that, against all odds, DehydraTECH seems to have a dramatic and positive effect on the oral delivery of a GLP-1 drug known as semaglutide. That drug, owned by Novo Nordisk and sold under the brand names Ozempic, Rybelsus, and Wegovy, has propelled Novo Nordisk to become the most highly valued public company in all of Europe. This was also our first-ever evidence that DehydraTECH could enhance delivery performance of so-called "large molecules". I am more positive than ever before about our chances of establishing a commercial relationship with a significant pharmaceutical company in the year to come. Why? Because: we have never been more confident in our intellectual property portfolio; we have witnessed consistent drug delivery improvements with a variety of molecules; we have established a foundation for our studied molecules to better qualify them for commercial use and have learned what must be done in advance of gaining a corporate partnership; and we have now demonstrated DehydraTECH's superiority with one of the most valuable molecule classes in the world. Our 2024 research program for GLP-1 drugs is ambitious but logical. It is well within our ability to execute. And, if it continues to deliver results similar to those we've already seen, together with our ever-advancing progress on DehydraTECH-related intellectual property, I'm just not aware of what else we would need to do in order to find a strong commercial partner. I have been a shareholder of Lexaria for a very long time: I know how our shareholders feel as you watch our progress because I feel most of the same things you do. I've always tried to be straight-up with you even as we've juggled some daunting challenges. We have new shareholders in 2023 who have enthusiastically supported our most recent corporate strategies - to you I offer a special "thank you" for your support and I pledge that I will do all that I can to turn 2024 into the year that Lexaria leaps forward."
|
CYTO | Hot Stocks08:50 EST Altamira Therapeutics files second provisional patent application for OligoPhore - Altamira Therapeutics has filed a second provisional patent application with the United States Patent and Trade Office to provide broad coverage of different KRAS mutations in human cancer treatment with nanoparticles comprising the Company's OligoPhore platform and a single siRNA sequence, polyKRASmut. The nanoparticles are developed by Altamira as AM-401. The second provisional application contains in vitro data confirming the ability of polyKRASmut siRNA to knock down a broad range of KRAS mutations in cancer cell lines. These mutations include G12C, G12V, G12D, G12R, G12A, and A146T, which account for 90.9% of KRAS mutations reported in pancreatic ductal adenocarcinoma, 65.3% in colorectal cancer and 80.0% in non-small cell lung cancer. In comparison, currently approved small molecule inhibitors target just one KRAS mutation, which represents 1.7%, 7.1% and 41.0% of total KRAS mutations in PDAC, CRC and NSCLC, respectively. Since polyKRASmut was tested against only a limited number of mutations, it may potentially knock down other, yet untested mutations. Altamira expects the second provisional patent application to further strengthen its intellectual property around the AM-401 program, under which the Company is aiming to develop a treatment for KRAS-driven cancers. Previous in vitro and in vivo work demonstrated efficient uptake of OligoPhore nanoparticles with KRAS-targeted siRNA in CRC and PDAC cells, strong inhibition of KRAS expression, reduced viability of tumor cells, and significant reduction in tumor growth and volume.2 Importantly, a murine model demonstrated the capacity of the OligoPhore platform to drive targeted delivery of the nanoparticles specifically to tumor cells. Altamira intends to file for an Investigational New Drug application with the FDA in 2025 and to partner the program upon an IND grant or following a phase 1 clinical trial.
|
PATH | Hot Stocks08:47 EST UiPath and Deloitte partner in AI-powered solutions to SAP technology - UiPath and Deloitte announced an alliance expansion to accelerate the transformation of their clients' businesses through a new focus on bringing AI-powered Intelligent Automation solutions to SAP implementations and operations. The expansion will serve as a catalyst to develop an innovative AI-led delivery methodology and new solutions for autonomous business operations, accelerating their joint clients' SAP S/4HANA transformation goals. As a part of this expansion, UiPath and Deloitte will create a co-innovation market collaboration, combining Deloitte's SAP implementation skillset and AI talent pool with UiPath's AI and automation technology. By including UiPath with the SAP Build Process Automation solution for SAP S/4HANA implementations, clients can cover both non-SAP and SAP workloads.
|
AZ | Hot Stocks08:43 EST A2Z Smart Technologies secures purchase order for 500 smart carts - A2Z Smart Technologies announced that, subsequent to the approval on January 23, 2024, of its board of directors, Cust2mate Ltd. has entered into an initial purchase order for 500 smart carts to be deployed in one of the largest retail chains in Belgium, with the smart carts expected to be deployed by the end of 2024. The purchase agreement includes an upfront fee, guaranteed monthly payments, and a revenue-sharing model for the value-added services provided by A2Z's Cust2mate Smart Cart technology.
|
YHGJ | Hot Stocks08:42 EST Yunhong Green CTI forms Yunhong Technology Industry Co. subsidiary - Yunhong Green CTI announced the formation of a new subsidiary and related intended acquisition of an operating facility to advance the business of compostable, biodegradable and recyclable materials to enhance environmental sustainability. In anticipation of the expected acquisition of this facility, the Company's Board of Directors has authorized the use of up to 5 million shares of our common stock to acquire the facility and its related operational expenses. The address of this newly formed subsidiary is: Yunhong Technology Industry Co., Ltd., Yunhong Health Industrial Park, No. 1, Jiangbei First Class Highway, Qianlu Village, Tianzhen Office, Wuxue City, Huanggang City, Hubei Province, The People's Republic of China.
|
NEM | Hot Stocks08:39 EST Newmont appoints Peter Wexler as Chief Legal Officer - Newmont Corporation announced the appointment of Peter Wexler as Chief Legal Officer. Peter will join Newmont's Executive Leadership Team and be responsible for leading the company's legal, compliance and regulatory affairs globally. "Peter's appointment further strengthens Newmont's Executive Leadership Team," said Tom Palmer, Newmont President and CEO. "Peter brings decades of world-class legal and risk management experience at global organizations, which will be invaluable as Newmont continues to grow, building on its position as the world's leading gold mining company and robust copper producer. We are excited to welcome him to Newmont
|
T | Hot Stocks08:38 EST AT&T says making 'strong early progress' on new cost savings target - Comments taken from Q4 earnings conference call.
|
IMMX | Hot Stocks08:38 EST Immix Biopharma 'applauds' FDA labeling change notification for CAR-T products - Immix Biopharma announced a statement on January 2024, FDA labeling change notifications for approved CAR-T products: "We applaud FDA's vigilance. Relapsed/refractory AL Amyloidosis remains an unmet medical need with limited treatment options. We believe that Immix Biopharma's CAR-T candidates, with demonstrated 'Single-Day CRS' and a marked lack of neurotoxicity in our ongoing Phase 1b/2 clinical trial, will continue to exhibit a favorable tolerability profile moving forward. In our interim clinical data to date, we have not observed any secondary T-cell malignancies," said Ilya Rachman, MD, PhD, Immix Biopharma Chief Executive Officer. Gabriel Morris, Chief Financial Officer of Immix Biopharma, added, "We believe NXC-201 will be uniquely suited to treat AL Amyloidosis and other autoimmune indications, given our interim clinical data in 73 patients to-date."
|
EVAX | Hot Stocks08:37 EST Evaxion to develop tailored cancer vaccines based on AI-discovered targets - Evaxion Biotech announces an expanded commitment to developing tailored cancer vaccines by targeting a novel category of AI-identified tumor antigens, named Endogenous Retroviruses. The new treatment opportunity may broaden the applicability of cancer vaccines. Through the new vaccine targets, ERVs, treating patients unresponsive to conventional cancer immunotherapy may become possible. With the elevated focus on this groundbreaking therapeutic concept, Evaxion has initiated preclinical activities with a goal of generating Proof-of-Concept data by the second half of 2024.
|
RSLS | Hot Stocks08:36 EST ReShape conducts bariatric surgical fellows training for Lap-Band system - ReShape Lifesciences announced that bariatric surgical fellows from the University of Texas Health Center in Houston, Texas were trained on Friday, January 19th, on the Lap-Band System and also received an introduction to the Company's new Lap-Band 2.0 FLEX. The training was hosted by Erik B. Wilson, M.D., Professor of Surgery at McGovern Medical School at the University of Texas Health Science Center, Houston, TX, Director of the UT Physicians Minimally Invasive Surgeons of Texas, and was co-led by Christine Ren-Fielding, M.D., Professor of Surgery at NYU Grossman School of Medicine, Director of the NYU Langone Weight Management Program and Chief of the Division of Bariatric Surgery. "Training surgical fellows on our Lap-Band System provided ReShape the opportunity to introduce the next generation of bariatric surgeons to our FDA approved, minimally invasive, long-term treatment for obesity," stated Paul Hickey, President and Chief Executive Officer of ReShape Lifesciences. "I am particularly excited that we were also able to introduce our recently approved Lap-Band 2.0 FLEX, designed to improve the patient experience, as the future of the Lap-Band(R) is inextricably tied to its continued adoption by surgeons. Similar to our existing Lap-Band, the Lap-Band 2.0 FLEX technology acts as a relief valve, allowing larger pieces of food to more easily pass through the narrowed passage, created by the band. We continue to believe that the Lap-Band System offers the safest, enduring weight loss solution for patients who have historically struggled with managing their weight and are committed to expanding its visibility in the bariatric market."
|
OMQS | Hot Stocks08:35 EST Omniq receives $5M in Purchase Orders for supply of hardware, software, more - OMNIQ announced that it received $5.0M in Purchase Orders for Hardware, software, IT licenses and services from one of the largest Food and Drugs chains in the US. The order includes IOT Supply Chain devices, software, services and support, which omniQ will provide. The project aims to modernize and upgrade the customer's equipment based on handheld devices, used in managing the customer's total supply chain level operations within its warehouses, distribution centers, and up to the point of delivery to their customer. Shai Lustgarten, CEO, of omniQ commented "We are proud to announce this order with innovative features from one of the largest and most prestigious corporations worldwide. Our team's dedication to meeting the evolving demands of our long-standing customers has been instrumental in fostering enduring partnerships and significant orders."
|
GNS LZGI | Hot Stocks08:35 EST Genius Group, FatBrain AI enter definitive merger agreement - Genius (GNS) and FatBrain AI (LZGI) signed a definitive merger agreement to power ecosystems of tomorrow for entrepreneurs, enterprises, governments and students through AI education and enablement. The to be combined businesses are preliminarily estimated to have achieved approximately $80 million of gross revenue in 2023, up over 100% year-on-year. Genius Group and FatBrain AI together enable an exponential growth cycle with AI edtech platform supporting over a five million student and a fifteen thousand partner marketplace joining peer intelligence and AI solutions across energy, finance, logistics, manufacture, retail, tech and telco sectors delivered to SMEs, enterprises and government institutions. Our full end-to-end AI Education and Acceleration ecosystem, has four global revenue drivers focused at B2S, B2C, B2B and B2G: B2B - For Students: Government and company funded AI camps and accelerators together with a scholarship fund for young students at high school and university level to learn future-focused skills, both virtual and in-person, personalized with their Genie AI. The Genius Curriculum progress through to full undergraduate and masters degree programs integrating with personalized gamified and Genius Metaversity, with AI-driven learning libraries shared across participating students and institutions. B2E - For Entrepreneurs: Full suite of upskilling courses in AI, exponential technologies and entrepreneurship, delivered by certified trainers and partners globally, ranging from AI Microschools to three-month in-house accelerators, linked with the Genius Scholarship to connect student apprentices with entrepreneurs and enterprises, and linked to FatBrain AI's SAAS solutions to share peer intelligence, industry trends and leaderboards. B2B - For Businesses: Enterprise portal and suite of upskilling courses for companies to upskill their workforce in AI, exponential technologies and entrepreneurship, delivered in-house, in-person and via the GeniusU Edtech platform, giving companies AI-powered insights into their workforce's personalized talent development progress and access to FatBrain AI's SAAS solutions to increase peer intelligence and productivity. B2G - For Governments: A full AI education ecosystem providing participating cities, regions and national governments with a full AI-driven, lifelong learning system for future-focused education and upskilling, with direct benefits in increased skills, competitiveness and shared intelligence within the rapidly changing Age of AI and Exponential Technologies. The merger has been approved by the boards of both companies, a definitive agreement has been signed and the merger will close subject to fulfillment of certain closing conditions, including, but not limited to, shareholder and NYSE approval. Following the closing of the merger, FatBrain AI's CEO, Peter B. Ritz, and Executive Chair, Michael T. Moe, will join Genius Group's Board. Peter B. Ritz is co-founder of FatBrain AI and earlier Exec Chair of Observable Networks. Michael T. Moe is Founder of GSV, an early investor in Edtech companies including Coursera, Chegg, Course Hero, Masterclass, and private investor in companies such as Meta, Twitter, Spotify, Coursera and Palantir.
|
DGLY | Hot Stocks08:34 EST Digital Ally announces University security order - Digital Ally announced a notable order for multiple FirstVu Pro body-worn cameras, EVO-HD in-car systems and QuickVu docking station to be deployed campus-wide by Kansas State University in Manhattan, Kansas. "We're proud to partner with Chief Grice in his division's efforts to optimize safety and security on Kansas State University's campus," said Brody Green, President of Digital Ally, adding, "We appreciate the university's long-time commitment to Digital Ally as we partner in keeping our communities safe."
|
ELAB | Hot Stocks08:33 EST Elevai Labs announces issuance of patent from USPTO - ELEVAI LABS announces that the United States Patent & Trademark Office, USPTO, issued US Patent No. 11,878,038, entitled "Exosome-based Skincare Product" covering the primary formulation for ELEVAI's exosome-based skin care products. The ELEVAI exosomes used in ELEVAI Labs' formulations are derived from specially cultured and treated umbilical mesenchymal stem cells to generate a specific profile for the applications desired. ELEVAI's enfinity and empower(TM) formulations are both covered by the Patent. "We are pleased the USPTO has issued this critical patent, which is the first step towards building ELEVAI's patent moat in the aesthetics market. The Company will continue to strive to invent or acquire the best and most technically advanced products, which we believe will maintain ELEVAI's competitive edge in the physician-dispensed skincare market and beyond," said ELEVAI co-founder and CEO, Jordan Plews, PhD.
|
BLIN | Hot Stocks08:32 EST Bridgeline Digital's Hawksearch selected by leading building materials retailer - Bridgeline Digital announced that a leading building materials retailer has selected Bridgeline's AI-powered search technology, HawkSearch, to enhance their eCommerce site. The building materials retailer has selected HawkSearch to increase revenue by improving product discovery within their newly expanded catalog of over 5,000 products. The retailers' online catalog will become more user-friendly with HawkSearch, due to navigation tools like autocomplete, drop-down menus, and faceted search results. Ari Kahn, CEO of Bridgeline Digital, commented on the partnership, stating, "Partnering with a growing eCommerce brand as they expand their online catalog marks a step in our efforts to enhance engagement in the building materials industry. The integration of HawkSearch into their eCommerce platform is pivotal in using advanced search technology to improve how customers interact with and navigate extensive online catalogs in the building materials sector, contributing to a more efficient online shopping experience."
|
NKSH | Hot Stocks08:32 EST National Bankshares to acquire Frontier Community Bank in $17.1M transaction - National Bankshares and Frontier Community Bank announced that they have entered into a definitive merger agreement for National Bankshares to acquire Frontier. As of September 30, 2023, Frontier had total assets of approximately $154 million. Upon completion of the transaction, National Bankshares is expected to have total consolidated assets of approximately $1.7 billion based on September 30, 2023 financial data. Under the terms of the merger agreement, shareholders of Frontier will have the right to receive either 0.4250 shares of National Bankshares common stock or $14.48 in cash for each share of Frontier common stock they hold. Shareholder elections are subject to adjustment so that the overall mix of consideration to be paid to Frontier shareholders consists of at least 90% National Bankshares common stock. The aggregate value of the transaction is approximately $17.1 million. Upon completion of the acquisition, Frontier will merge into The National Bank of Blacksburg, the wholly owned bank subsidiary of National Bankshares. The transaction, which received unanimous approval by both National Bankshares' and Frontier's Board of Directors, is subject to customary closing conditions, including the approval of the merger agreement by Frontier's shareholders and the receipt of all required regulatory approvals. All executive officers and directors of Frontier have entered into support agreements to vote the shares of Frontier they own in favor of the transaction. The transaction is expected to close in the second quarter of 2024.
|
POWW | Hot Stocks08:31 EST AMMO announces international supply agreement with ZRODelta - AMMO announces that it has signed a supply agreement with ZRODelta to provide 6+ million brass cases for the fulfillment of international contracts. ZRODelta is a specialized manufacturer of high-precision and high-volume firearms and ammunition. In the agreement AMMO will supply ZRODelta with 6+ million brass cases of 12.7x108 beginning in June of 2024. The Company expects delivery to be completed by February of 2025. Management believes the value of the contract will exceed $10 million over that time period. Jared Smith, CEO of AMMO stated, "This supply agreement is a great first foray into the expansion of our footprint into international markets. In addition, this is another opportunity to leverage our increased manufacturing capacity at our new facility in Manitowoc, which we are confident will produce and deliver the order on schedule."
|
PSQH | Hot Stocks08:26 EST PSQ Holdings and BNPL firm Credova team on sales, financing for firearms - PSQ Holdings and Credova announced they have agreed to a partnership that will implement Credova BNPL technology into the PublicSquare platform. The partnership will provide PublicSquare access to Credova's approximately 2.8 million customers and 4,000 values-aligned vendors and provides the first step in PublicSquare's efforts to build an uncancellable payment ecosystem for the parallel economy. The partnership is expected to launch during the second quarter of 2024. Michael Seifert, Chairman and Chief Executive Officer of PublicSquare, commented, "Our partnership with Credova is an important next step in the maturation of the PublicSquare ecosystem and helps solidify the parallel economy's economic engine. The partnership supercharges the PublicSquare platform with an immediate customer value proposition, plus immediate access to Credova's formidable client base, particularly in the firearms, recreational, and personal defense industries. Through the integration of the capabilities of Credova's Buy Now Pay Later payments technology, we open the door for both our consumers and merchants to explore sales and financing opportunities that may have been previously unavailable. Further, this partnership ensures that purchases in the PublicSquare marketplace remain secure from cancellations, helping to protect Second Amendment rights, a crucial and necessary safeguard for the parallel economy. We are excited for our partnership with the excellence-driven Credova team."
|
MODD | Hot Stocks08:25 EST Modular Medical announces issuance of U.S. patent - Modular Medical announced the issuance of U.S. Patent 11,817,197 B2 for the stream-lined pairing of a pump to a mobile device.
|
PRSO | Hot Stocks08:24 EST Peraso announces first commercial order utilizing DUNE Platform - Peraso announced an order for its Perspectus mmWave antenna modules that support the DUNE platform, demonstrating the Company's ability to address broadband infrastructure challenges in informal settlements. The DUNE platform implements intelligent Media Access Control features, which, along with the Perspectus series of modules, enable wireless Internet service provider operators to deploy long range, multi-point networks without interference in dense user environments. Peraso's latest mmWave antenna module, the PRM2144X, is specifically designed for dense urban areas. A novel 128 element, integrated, phased array antenna, provides high gain, narrow beamwidth and extremely low antenna side-lobes. The increased gain and range also benefit suburban and rural deployments, eliminating the need for dish antennas in many cases.
|
RUN | Hot Stocks08:23 EST SOMAH, St. Mary's Elderly Housing, AP Environmental partner with Sunrun - The Solar on Multifamily Affordable Housing, SOMAH, Program, St. Mary's Elderly Housing Corporation, and Asian Pacific, AP, Environmental Network have partnered with Sunrun for a ribbon-cutting ceremony to celebrate a new rooftop solar installation at St. Mary's Gardens, an affordable housing community in Oakland, California. "It is gratifying to connect affordable housing communities and families to a cleaner energy source and provide them with the many benefits that come with solar energy," said Sunrun CEO Mary Powell. "Rooftop solar effectively removes the variable risk of energy inflation for affordable housing developments. We are proud to promote energy equity while delivering meaningful monthly savings to the residents of St. Mary's Gardens."
|
FPRGF GLNCY | Hot Stocks08:23 EST Falco executes operating license, indemnity agreement with Glencore Canada - Falco Resources (FPRGF) has entered into an operating license and indemnity agreement with Glencore Canada Corporation (GLNCY) pursuant to which Glencore granted to Falco, subject to the terms and conditions contained in the OLIA, a license to utilize a portion of its lands, which Falco will use to develop and operate Falco's wholly-owned Horne 5 project located in Rouyn-Noranda. The OLIA was entered into further to the preliminary agreement in principle with Glencore announced on June 28, 2021. The OLIA establishes the framework to govern Falco's development and operation of its world-class Horne 5 Project, taking into account its overlap with and close proximity to Glencore's copper smelting operations at the Horne smelter in Rouyn-Noranda. The key features of the OLIA include: The creation of a Technical Committee comprised of two representatives of each of Falco and Glencore, to determine ongoing operating parameters within which Falco can conduct operations of the Horne 5 Project so as not to interfere with the Horne Smelter, minimize and control risks to the Horne Smelter and where necessary adopt mitigation measures. The creation of a Strategic Committee comprised of two representatives of each of Falco and Glencore, to collaborate and exchange information in connection with the development and operation of the Horne 5 Project, its interaction with the Horne Smelter and community and regulatory matters, and to capitalize on the many synergies between the parties. The right of Glencore to appoint one nominee to Falco's board of directors. The adoption of principles pursuant to which Glencore and its Horne Smelter retain priority over the operations of the Horne 5 Project as contemplated in the OLIA and must be afforded protection from incremental risks and losses occasioned by Falco's Horne 5 Project. Financial assurances, guarantees and indemnification to be provided by Falco to Glencore to cover incremental risks and losses to Glencore and its Horne Smelter arising from Falco's operations and certain other matters specified in the OLIA. The right of Glencore to require remediation, suspension or other risk-mitigation during the operations of Falco's Horne 5 Project to protect Glencore's Horne Smelter and related operations, subject to expert intervention and dispute resolution mechanisms set out in the OLIA. As previously disclosed, starting in November 2020, Glencore and Falco have conducted an intensive Work Program to address concerns and mitigate potential risks to Glencore's Horne Smelter. Key components of the Work Program were established by Glencore after a due diligence review of the Horne 5 Project by the parties' technical teams, and included geotechnical advancement, water management and synergies between the Horne 5 Project and the Horne Smelter. Falco and Glencore have made material progress on the key components of the Work Program and will continue to collaborate to finalize outstanding matters for the Horne 5 Project and proceed with dewatering, construction and operation of the Horne 5 Project, subject to the conditions set out in the OLIA. The ability of Falco to commence certain conditioned activities under the OLIA, including dewatering and mining activities of the Horne 5 Project, is subject to Falco providing Glencore at the relevant time, financial assurances in the form of letters of credit, performance guarantee or similar guarantees. The OLIA provides that financial assurances must be posted by Falco in the amount of C$40 million for the dewatering phase, increasing to C$80 million during the mining phase and decreasing to between C$10 million and C$20 million during the closure and remediation phases, subject to certain conditions and inflation-related adjustments after a specified number of years. Glencore will have the right to draw upon such financial assurances in the event that it incurs losses subject to indemnification by Falco under the OLIA. The OLIA also requires Falco to provide Glencore specified coverage under insurance policies to address certain risks to Glencore and its Horne Smelter arising from Falco's Horne 5 Project, before the commencement of dewatering and mining activities. Falco is confident based on its discussions with insurance brokers and underwriters that such coverage can be obtained on reasonable terms when required.
|
LSPD | Hot Stocks08:21 EST Lightspeed announces launch of Lightspeed Scheduling - Lightspeed Commerce announced the launch of Lightspeed Scheduling-an all-new booking management tool released to golf course operators. Lightspeed Scheduling enables golf facilities to serve a broader audience and drive additional revenue by easily taking bookings for as many off-course services as they need, straight from Lightspeed's one-stop golf management platform. "We are incredibly excited about the official release of Lightspeed Scheduling and for the opportunities it creates for the courses we work with," said David Hope, General Manager, Lightspeed Golf. "Our job as their technology partner is to provide tools that help them solve their unique operational challenges, adapt to industry changes, improve customer touchpoints and scale their businesses. We believe the addition of Lightspeed Scheduling to our core Lightspeed Golf platform helps courses do just that, as well as gain an edge over their competition."
|
CG | Hot Stocks08:21 EST Carlyle acquires $415M private student loan portfolio and invests in Monogram - Carlyle acquired a $415M private student loan portfolio, and strategic investment into Monogram, a leading provider of finance solutions for students and their families. Led by the former management team of Cognition Financial and backed by Carlyle, Monogram will partner with Carlyle to originate, acquire, and manage high-quality third-party private student loan assets. The Monogram platform provides a fully outsourced, end-to-end private student loan solution for lenders. Monogram currently has more than $7B in private student loans under management.
|
ATLC | Hot Stocks08:20 EST Atlanticus announces offering of senior notes - Atlanticus Holdings announced it has commenced an underwritten registered public offering of Senior Notes due 2029. The Company expects to grant the underwriters a 30-day option to purchase additional Notes in connection with the Offering. The Company expects to use the net proceeds of this Offering to redeem a portion of the Class B preferred units issued by one of the Company's subsidiaries and/or for general corporate purposes. In connection with the Offering, the Company will apply to list the Notes on the Nasdaq Global Select Market under the symbol "ATLCZ." If approved for listing, trading on Nasdaq is expected to commence within 30 business days after the Notes are first issued. B. Riley Securities, Inc., Janney Montgomery Scott LLC, Ladenburg Thalmann & Co. Inc., William Blair & Co., L.L.C., and BTIG, LLC are acting as book-running managers for this Offering. Brownstone Investment Group, LLC is acting as co-manager for this Offering.
|
OR AEM | Hot Stocks08:18 EST Osisko appoints David Smith to its board of directors - Osisko Gold Royalties (OR) announces the appointment of David Smith to its Board of Directors. Most recently, Smith retired as Executive Vice-President, Finance and Chief Financial Officer of Agnico Eagle Mines (AEM) in May 2023, having held the position since 2012.
|
SRAD | Hot Stocks08:18 EST Sportradar CFO Gerard Griffin to depart - Griffin has informed the Company that he will be leaving for personal reasons. Griffin will continue as CFO until May 31, 2024, or the appointment of a permanent successor, if earlier. The Company has initiated a search for its next CFO, whom it expects to announce prior to Griffin's departure
|
SRAD | Hot Stocks08:18 EST Sportradar CSO Ulrich Harmuth to depart - As part of the organizational changes, Ulrich Harmuth, Chief Strategy Officer, will be departing the Company to pursue other endeavors.
|
SRAD | Hot Stocks08:17 EST Sportradar announces new organizational structure - Sportradar Group announced additional strategic actions as part of its previously announced initiatives to streamline its organizational structure to enhance focus on clients and partners, drive global innovation and product development, and propel long-term growth, profitability, and shareholder value. "I am excited to announce this new global organization and leadership structure, which aligns our teams on our strategic priorities, promotes agile execution and better positions Sportradar for future growth," said Carsten Koerl, CEO of Sportradar. "By centralizing our key business functions, we will foster greater collaboration and faster decision making, enabling us to drive further operating efficiencies and increased innovation across our business. These decisive steps will enable us to better serve our clients and partners as well as capture the significant market opportunities ahead of us. I am confident we have the right leaders in place, intently focused on executing on our strategic priorities. For 2023, we remain on track to deliver on our strong growth targets and are well positioned to maintain that momentum into 2024." Effective immediately, the new organizational structure consists of six business functions: Product Delivery and Operations combines and centralizes content, product development and engineering globally to seamlessly deliver best-in-class products and solutions to clients and partners, led by Warren Murphy, previously Chief Product Officer and now Chief Delivery and Operations Officer.; Growth and Innovation combines growth, strategy and innovation to facilitate a unified vision for identifying and capitalizing on market opportunities, thereby ensuring a well-defined growth strategy fueled by continuous innovation, led by Nick Maywald, previously Chief Content Officer and now Chief Growth and Innovation Officer. Commercial combines the Company's go-to-market functions, including sales, client services and care, sports partnerships, marketing and communications to further drive revenue opportunities while enhancing its client- and partner-centric approach, led by Chief Commercial Officer Eduard Blonk. Legal, Risk and Administrative Services, led by Lynn McCreary, Chief Administrative Officer, Chief Legal Officer and Corporate Secretary. People, led by Severine Riviere-Gerstner, Chief People Officer. Finance, led by Gerard Griffin, Chief Financial Officer.
|
RDVT | Hot Stocks08:17 EST Red Violet's FOREWARN partners with MLS United - FOREWARN, a subsidiary of red violet company, announced that it has partnered with MLS United, the largest Multiple Listing Service in Mississippi. This collaboration will extend FOREWARN services to over 6,200+ MLS United customers at no additional cost to individual agents. Available both online and through a mobile application, FOREWARN analyzes billions of data points and provides users with the ability to mitigate risks by verifying identity, searching for criminal histories, and validating information provided by potential clients. "We are thrilled to provide FOREWARN to our customers, enhancing their ability to work safely and guard against potential fraud," stated Joe Rogers, CEO of MLS United. "Real estate agents face various physical and fraudulent threats, and verifying the identity of unknown prospects is a crucial first step in self-protection. FOREWARN facilitates this process quickly and efficiently."
|
TWST | Hot Stocks08:17 EST Twist Bioscience expands express genes rapid synthesis service - Twist Bioscience announced the expansion of Twist Express Genes, a new leading gene synthesis service with an order to shipping turnaround starting at five business days1, to include larger DNA preparations up to 1 milligram. The Express Genes offering, initially launched in November 2023, now extends to larger midiprep and maxiprep DNA preparations. As with Twist standard speed Clonal Genes, all Twist Express Genes are NGS-verified as clonally perfect. "Since the initial launch of our Express Genes service in November, we have received positive and enthusiastic feedback from existing customers on our consistent and rapid turnaround time. By expanding Express Genes to include midiprep and maxiprep, we can now offer rapid gene synthesis at all gene prep scales, enabling large scale experimentation for pharmaceutical, biotechnology, academic and industrial chemical researchers," said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. "With the expanded offering of Twist Express Genes, more researchers can gain access to Twist genes fast and at scale, including those using alternative providers and those cloning their own genes. The ability to order and receive synthetic DNA fast and at scale means more time for cutting-edge research, more make-test-learn cycles, and an accelerated journey to game-changing discoveries."
|
VCIG | Hot Stocks08:15 EST VCI Global's real estate arm acquisires Impiana Private Villas Kata Noi - V Capital Real Estate Sdn Bhd, the real estate arm and a subsidiary of VCI Global, announced that it has executed an agreement with Haad Sai Ngen for the acquisition of leasing rights for land, including Impiana Private Villas Kata Noi, Phuket, and its associated assets. Upon VCI Global's acquisition of the leasing rights for an approximately 2,902 square meters land area in Karon Sub-District, Muang Phuket District, Phuket Province, Thailand, the Company secures Impiana Private Villas Kata Noi, Phuket along with all its associated assets. Impiana Private Villas Kata Noi comprises 11 villas, covering 1,085 square meters, occupying less than 40% of its land area. This presents a promising opportunity for potential future expansion. Dato' Victor Hoo, Group Executive Chairman and Chief Executive Officer of VCI Global said, "Thailand's hospitality industry is expected to reach $19 billion by 2028, giving a 5-year compound average growth rate of almost 30%. Aligned with our strategy to explore opportunities in the Southeast Asia hospitality sector, we consider the acquisition of Impiana Private Villas Kata Noi a strategic investment. We anticipate further prospects in hospitality, fostering growth of our subsidiary, V Capital Real Estate Sdn Bhd."
|
URGN | Hot Stocks08:15 EST UroGen initiates submission of rolling NDA to FDA for UGN-102 - UroGen Pharma announced the submission of the Chemistry, Manufacturing, and Controls CMC section of the New Drug Application NDA for UGN-102 mitomycin for intravesical solution to the U.S. Food and Drug Administration FDA . "The submission of the CMC portion of the NDA for UGN-102 marks a significant milestone for UroGen and underscores our dedication to advancing innovative therapies for the benefit of individuals grappling with low-grade, intermediate-risk non-muscle invasive bladder cancer," said Liz Barrett, President and CEO, UroGen. "We look forward to working closely with the FDA throughout the review process and remain steadfast in our commitment to address unmet medical needs in the uro-oncology space and advance patient care." The objective of the rolling NDA for UGN-102 is to facilitate early engagement with the FDA, and a more efficient and timely review of the NDA. Based on its agreement with the FDA, UroGen will complete the submission of the rolling NDA for UGN-102 in 2024 with a potential FDA decision as early as the first quarter of 2025.
|
TFFP | Hot Stocks08:14 EST TFF Pharmaceuticals to present data from its Phase 2 trial of TFF VORI - TFF Pharmaceuticals announced that the Company will present data from the Phase 2 trial of Voriconazole Inhalation Powder, TFF VORI, for the treatment of invasive pulmonary aspergillosis at the upcoming Advances Against Aspergillosis & Mucormycosis, AAAM, Conference, which will be held from January 25-27, 2024, in Milan, Italy. Data being presented at the AAAM Conference were first disclosed by the Company in December 2023.
|
ANVS | Hot Stocks08:12 EST Annovis Bio postpones Parkinson's Phase III study data announcement - Annovis Bio has announced a postponement in the Phase III study data release for buntanetap in Parkinson's Disease. This adjustment is due to ongoing data cleaning efforts to ensure the accuracy and reliability of the study results. "We acknowledge the ongoing anticipation for the Phase III data announcement initially set for the end of January 2024. However, the delivery of the cleaned data is now delayed as we work to provide the most accurate results by ensuring the process is conducted diligently and thoroughly," said Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis. "During this period, the Company remains blinded to the data, and the statistical analysis is yet to be performed. We understand your potential frustration with the required extension, and we want to stress that our focus is on delivering results that are trustworthy. We are working hard to provide them to you very soon." The Company is dedicated to maintaining open communication and will continue to provide updates for Parkinson's Phase III study results in a timely and informative manner.
|
WKSP | Hot Stocks08:11 EST Worksport unveils AL3 PRO hard-folding tonneau cover - Worksport announced the launch of its first hard-folding tonneau cover, the Worksport AL3 PRO Low Profile Aluminum Tonneau Cover - a flush mounted, three panel, all aluminum tonneau cover. Embodying the perfect blend of durability, style, and functionality, this new product is proudly Made in the USA and is set to redefine standards in the truck accessory market.
|
HON | Hot Stocks08:10 EST Honeywell selected by Acelen Renewables for renewable diesel fuel production - Honeywell's Ecofining technology has been selected by Acelen Renewables to help support the efficient production of a targeted 20,000 barrels per day of sustainable aviation fuel - SAF - and renewable diesel. The fuels will be processed at Acelen's facility in Bahia, Brazil, from a blend of inedible seed and waste oils. Over 50 sites now license Honeywell's renewable fuels technology, capable of producing over 500,000 barrels per day at peak capacity.
|
RZLT | Hot Stocks08:09 EST Rezolute appoints Evans as Chief Financial Officer - Rezolute announced the addition of Daron Evans, MS, MBA, to its leadership team as Chief Financial Officer as well as the grant of share options as a material inducement for his appointment.
|
GSK | Hot Stocks08:09 EST GSK enters collaboration, licensing agreement with Elegen - Elegen announced a collaboration and licensing agreement with GSK to enable its use of Elegen's proprietary cell-free DNA manufacturing technology in the development of GSK's vaccines and medicines. The terms of the agreement include upfront fees and purchase commitments of Elegen's ENFINIA DNA to support GSK's development of medicines and vaccines, including RNA vaccines. Elegen is also eligible to receive both near-term milestone payments relating to the development of new product features and a potential equity investment in Elegen by GSK.
|
WIMI | Hot Stocks08:09 EST WiMi Hologram Cloud develops interactive system based on V-BCI technology - WiMi Hologram Cloud has integrated the visual-brain-computer interface into the holographic eyewear interaction system, resulting in a more efficient and immersive user experience. Currently, traditional human-computer interaction mainly relies on input methods such as gestures and voice, which has achieved a breakthrough in human-computer interaction, but still falls short in terms of the intuitiveness and efficiency of the user experience. In order to improve the interaction experience of holographic glasses, WiMi's V-BCI realizes direct communication between the brain and the computer by recording the user's EEG signals, thus enabling the user to manipulate AR content more intuitively and efficiently. However, to implement V-BCI technology in holographic eyewear applications, challenges such as real-time and accuracy of EEG devices need to be overcome. WiMi's V-BCI-based interaction technology for holographic eyewear utilizes lightweight wearable hardware designed for AR eyewear scenarios. The design of this hardware focuses on enabling a fast setup, reliable recording and comfortable wearable experience. Importantly, the hardware ensures highly accurate recording of EEG signals while being lightweight. It enables users to easily enjoy high-quality brain-computer interaction while wearing holographic glasses.
|
VNT | Hot Stocks08:09 EST Sparkion, Voltus partner to leverage energy storage - Sparkion, a Vontier company, announced its partnership with Voltus, a leading distributed energy resource platform and virtual power plant operator. The partnership will support grid reliability in the U.S. by enrolling EV sites with Sparkion controlled energy storage and DERs at commercial and industrial sites into Voltus's virtual power plant network. The collaboration with Voltus leverages energy storage as a dual-use asset and connects DERs to electricity markets in the U.S. to generate revenue for commercial and industrial energy users while contributing to a more sustainable and resilient electric grid.
|
BWMN | Hot Stocks08:08 EST Bowman gets two mining deals with combined $1.9M of assignments - Bowman Consulting Group has secured a combined $1.9M of assignments through two new mining contracts in Arizona. Under the first contract, Bowman will oversee the comprehensive design work for the SX plant feasibility study, which includes process, geotechnical, structural, mechanical and electrical engineering. The project for which Bowman will be providing design services includes two miles of haul road pavement and stormwater control design; survey services for stockpiled ore and mine water lines; leach pad construction; mined land reclamation; and mapping of a mine railroad. The second contract is for survey and construction quality assurance CQA services for a 53-acre leach pad. Bowman's CQA services will help to streamline the installation of liner subgrade, geomembrane and geosynthetic clay line, a solutions collection pipe network and the placement of over-liner drain rock.
|
HEPS | Hot Stocks08:08 EST Hepsiburada director Murat Emirdag resigns, Ahmet Toksoy appointed to board - D-MARKET Electronic Services & Tradingannounced a change to the composition of its Board of Directors. Effective January 15, 2024, Mr. Murat Emirdag, a former member of the Company's Board of Directors, resigned from his position and Mr. Ahmet Toksoy was appointed as a member of the Board of Directors to replace Mr. Murat Emirdag. The appointment of Mr. Ahmet Toksoy has been registered with the trade registry on January 23, 2024 and it will be submitted for approval at the Company's next general assembly meeting of shareholders. Mr. Toksoy held the position of Head of Financial Affairs of Hurriyet Newspaper from 1998 to early 2010s, and over the years, took on various positions at Dogan Group such as the Head of Audit and Risk Management of Dogan Holding, the Chairman of the Board of Directors of Hurriyet Newspaper, and member of the Board of Directors of various affiliate companies of Dogan Group.
|
SLNO... | Hot Stocks08:07 EST Soleno Therapeutics announces appointments to its leadership team - Soleno Therapeutics (SLNO) announced the appointments of Meredith Manning, M.B.A as Chief Commercial Officer, Dairine Dempsey, Ph.D. as Vice President, Europe and Lauren Budesheim, M.S. as Vice President of Human Resources. The Company also announced the appointment of key advisors with Shamim Ruff, M.S. joining as Chair of the Development Advisory Board and James Geraghty, J.D., M.S. as a Board Advisor. Prior to joining Soleno, Meredith Manning served as President of the Americas and a member of the U.S. Board of Directors at PharmaEssentia. Dairine Dempsey has been a consultant to Soleno since 2019. Lauren Budesheim previously served as Head of People at Neurona Therapeutics. Shamim Ruff is currently the Chief Regulatory Affairs Officer and SVP, Head of Quality Assurance at Stoke Therapeutics (STOK). James Geraghty serves as the Chairman of the Board of Directors for Orchard Therapeutics (ORTX), Pieris Pharmaceuticals (PIRS) and OMass Therapeutics.
|
AMEH | Hot Stocks08:07 EST Apollo Medical announces corporate rebrand as Astrana Health on February 26 - Apollo Medical plans to change its name to Astrana Health, effective February 26. Alongside the planned corporate name change, the company's common stock is intended to begin trading under the new symbol "ASTH" on the NASDAQ, effective February 26. Branding across the company will be rolled out in phases and will transition over the coming months.
|
AMEH | Hot Stocks08:07 EST Apollo Medical announces senior leadership transitions - Apollo Medical Holdings announced the following leadership transitions: Brandon Sim, the company's Co-CEO, has been named President and CEO, effective January 19. Dr. Thomas Lam will serve as Vice Chairman of the Board of Directors and is retiring as President and Co-CEO, effective January 19. Chan Basho remains CFO and, in addition, has been named COO, effective January 19. Dr. Dinesh Kumar will be joining the executive team as Chief Medical Officer of ApolloMed, effective January 23.
|
SFNC | Hot Stocks08:05 EST Simmons First National increases dividend 5% to 21c per share - Simmons First National declared a quarterly cash dividend on the company's Class A common stock of 21c per share, which is payable on April 1 to shareholders of record as of March 15. The cash dividend rate represents an increase of 1c per share, or 5%, from the dividend paid for the same time period last year.
|
DM | Hot Stocks08:05 EST Desktop Metal announces additional $50M in cost reduction, workforce cuts - Desktop Metal announced an additional $50M cost-reduction plan that includes a 20% workforce reduction designed to align its cost structure to current market dynamics. The effort is part of a broader strategic business review and other actions, including continued consolidation of facilities and product rationalization, aimed at accelerating DM's path to profitability in the midst of a downturn in the additive manufacturing industry. "The cost-reduction plans announced today, in addition to the $100 million in cost reductions realized in 2023, will help us generate positive cash flow in light of a softer demand environment," said Ric Fulop, Founder and CEO of Desktop Metal. "We are committed to getting profitable during this challenging period. The vast majority of the cuts will be completed this quarter, resulting in sequential cost reductions across the first half of 2024. This latest action is expected to result in pre-tax restructuring charges of $24.3M to $31.5 M. The majority of those estimated charges are non-cash, with an estimated $5.3M to $7.5M of the restructuring charges coming from cash reserves. .
|
CTMX | Hot Stocks08:04 EST CytomX Therapeutics announces FDA clearance of IND applications for CX-2051 - CytomX Therapeutics announced that it has received clearance from the U.S. Food and Drug Administration, FDA, for its Investigational New Drug, IND, applications for the conditionally activated Probody therapeutics CX-2051, an EpCAM-directed ADC, and CX-801, a dually-masked version of interferon-alpha 2b. CX-2051 has been cleared for the initiation of Phase 1 dose escalation in solid tumors with known EpCAM expression and CX-801 has been cleared for the initiation of Phase 1 dose escalation in solid tumors including melanoma, renal, and head and neck squamous cell carcinoma. Both programs are expected to start Phase 1 studies in the first half of 2024. "CX-2051 and CX-801 have the potential to address major unmet needs in oncology and we are excited to advance these programs into Phase 1 clinical studies. CX-2051 is an ADC conjugated to a next-generation topoisomerase-1 inhibitor payload that we believe is tailored to certain EpCAM-expressing tumors, including colorectal cancer," said Wayne Chu, M.D., chief medical officer of CytomX Therapeutics. "CX-801 is designed to overcome previous limitations of interferon-directed therapies due to systemic toxicity and establish CX-801 as a cornerstone of combination regimens, including with checkpoint inhibitors, across a wide range of tumor types," continued Dr. Chu.
|
PATK | Hot Stocks08:04 EST Patrick Industries sees Q1 charge of $7M from acquisition of Sportech - Patrick Industries announced that it has completed its previously announced $315M acquisition of Sportech, a designer and manufacturer of high-value, complex component solutions to powersports OEMs, adjacent market OEMs and the aftermarket. In connection with the acquisition, the company expects to record one-time, non-recurring pretax charges in the first quarter of 2024 of approximately $7M related to transaction fees and non-cash purchase accounting adjustments.
|
BNGO | Hot Stocks08:03 EST Bionano Genomics announces publication of second interim report of trial on OGM - Bionano Genomics announced the publication of the second interim report from an ongoing clinical trial designed to support establishing OGM as part of standard of care in diagnosis of genetic disease for prenatal subjects. This publication reports on the prenatal genetic disease clinical trial program to evaluate OGM as an alternative to SOC workflows. This second interim readout is designed to evaluate endpoints connected to analytical performance using an expanded dataset in key areas of technical performance and clinical utility of OGM. The study is an Institutional Review Board-approved, multicenter, double-blinded trial with samples from 219 unique retrospective and prospective clinical research subjects. All samples had been previously tested with traditional methods including karyotyping, fluorescence in situ hybridization and chromosomal microarray. Key Findings: This publication describes OGM performance metrics including performance, robustness and reproducibility in prenatal samples when compared to SOC methods. Key findings for the technical endpoints were reported as follows: Results of OGM analysis were comparable, in a single assay, to the results of two separate standard of care tests needed to reach a diagnosis in 71.2% of cases and to three separate SOC tests needed to reach a diagnosis in 26.9% of cases. Compared to CMA, FISH and KT combined in this cohort, OGM had the following performance: Concordance: 100%; Sensitivity: 99.2%; Specificity: 100%; Positive Predictive Value: 100%; Negative Predictive Value: 95.5%; Overall accuracy: 99.6%. Key Takeaways: The publication concluded that these results demonstrate the technical performance and utility of the OGM workflow from DNA isolation through data analysis when compared to SOC methods. The authors noted that a single approach, like OGM, can allow genetic analysis laboratories to provide results that are comparable or even more informative than classical methods with a rapid cost-effective solution.
|
MCHP | Hot Stocks08:01 EST Microchip releases PIC16F13145 family of microcontrollers - To address the expanding need for increasing levels of customization in embedded applications, Microchip Technology is offering a tailored hardware solution with the launch of its PIC16F13145 family of microcontrollers. Outfitted with a new Core Independent Peripheral-the Configurable Logic Block module-the MCUs enable the creation of hardware-based, custom combinational logic functions directly within the MCU. Because of its integration into the MCU, the CLB allows designers to optimize the speed and response time of embedded control systems, eliminating the need for external logic components and reducing Bill of Materials cost and power consumption. The process is further simplified by a graphical interface tool, which helps synthesize custom logic designs using the CLB. The PIC16F13145 family is designed for applications utilizing custom protocols, task sequencing or I/O control to manage real-time control systems in the industrial and automotive sectors.
|
IRIX | Hot Stocks08:01 EST Iridex announces first patient enrollment in MicroPulse TLT study - Iridex Corporation announced the first patient enrollment in a collaborative medical research study and registry evaluating the treatment of glaucoma with MicroPulse(R) Transscleral Laser Therapy using Iridex' Cyclo G6 Laser and the MicroPulse P3 Delivery Device. This partnership establishes a large-scale enrollment platform to advance clinical research. David Bruce, President and CEO of Iridex, shared: "The first patient enrollment in this partnership with Imperial College Healthcare NHS Trust is the first step toward multicenter participation enabling a large-scale view and significant in-country impact of our MicroPulse technology." The study, titled "MicroPulse Transscleral Laser Therapy: A Prospective UK Study," is set to expand Iridex's global clinical portfolio, through its commitment to funding essential components of the 3-year study and providing a custom-designed and secure database management system. Both Iridex and Imperial College Healthcare NHS Trust are dedicated to conducting this study in accordance with the strictest ethical and regulatory standards and look forward to welcoming additional sites to join the program.
|
ZVSA | Hot Stocks08:00 EST ZyVersa Therapeutics announces peer-reviewed article on targeting ASC specks - ZyVersa Therapeutics announced that world renowned inflammasome researchers and inventors of ZyVersa's Inflammasome ASC Inhibitor IC 100 have published a scientific paper in the peer-reviewed journal, Alzheimer's & Dementia: Translational Research & Clinical Interventions. In the paper titled, "Association of region-specific hippocampal reduction of neurogranin with inflammasome proteins in postmortem brains of Alzheimer's disease," the researchers demonstrated that loss of plasticity and neuronal scaffolding proteins, part of the neurodegenerative process leading to memory and learning deficits in AD, is associated with recruitment of ASC molecules and formation of inflammasome complexes in both neurons and microglia. "Our data emphasize that the synapse may be more vulnerable when the inflammatory machinery is activated, supporting the potential role of targeting ASC specks during the progression of AD pathology," said Dr. Regina T. Vontell, Research Assistant Professor and Associate Director, Brain Endowment Bank at the University of Miami Miller School of Medicine. "Our earlier data demonstrated that ASC correlated with Abeta and p-tau in postmortem cases with AD pathology, and that neurons in areas of the brain that are particularly susceptible to death in the early and intermediate stages of the disease process could be identified through imaging studies with Inflammasome ASC inhibitor IC 100. This further supports the therapeutic potential of targeting ASC in patients with AD," stated Dr. Robert W. Keane, Professor, Physiology and Biophysics, Neurological Surgery and Microbiology, and Immunology at the University of Miami Miller School of Medicine, and a member of ZyVersa's Inflammatory Disease Scientific Advisory Board.
|
SPRC | Hot Stocks07:43 EST SciSparc announces $20M standby equity purchase agreement - SciSparc announced that it has entered into a standby equity purchase agreement with YA II PN, a fund managed by Yorkville Advisors Global, LP. Under the terms of SEPA, YA is committed to purchase up to $20 million of the Company's ordinary shares over the next thirty-six-month period, subject to a beneficial ownership cap of 4.99% of the share capital of the Company. The purchase price of the ordinary shares will be at a 3% discount of the weighted average price of the Company's ordinary shares during the three consecutive trading day period commencing on the trading day of the delivery of an advance notice by the Company. The Company will have the right in its sole discretion to sell shares to YA from time to time upon the issuance of an advance notice, which has no right to require the Company to sell any shares, following the effectiveness of a registration statement with the Securities and Exchange Commission registering the ordinary shares issuable pursuant to the SEPA and other customary closing conditions. The Company intends to use the proceeds from the potential offering of the ordinary shares pursuant to the SEPA for working capital and other general corporate purposes.
|
VTNR | Hot Stocks07:43 EST Fitch downgrades Vertex Energy to 'CCC+' - Fitch Ratings has downgraded Vertex Energy's and Vertex Refining Alabama LLC's Long-Term Issuer Default Ratings to 'CCC+' from 'B-'. Fitch has also downgraded the rating of Vertex Refining Alabama's senior secured term loan to 'B-'/'RR3' from 'B'/'RR3'. "The downgrade reflects Vertex's weaker liquidity buffer amid lower U.S. Gulf Coast refining crack spreads and weak Fitch-expected contribution from renewable diesel segment in 2024. The company's FCF generation is highly sensitive to refining crack spreads that declined in 4Q23 from abnormally high 2022-2023 levels. Its unrestricted cash balance fell from $141 million at YE 2022 to around $70-80 million at YE 2023. Fitch projects negative EBITDA and FCF for Vertex in 2024 based on the assumptions of continued crack spread normalization and weak renewable diesel profitability," the ratings agency stated. Reference Link
|
IDEX | Hot Stocks07:38 EST WAVE Charging integrates wireless charging tech into Kenworth electric trucks - WAVE Charging announces an achievement in the commercial EV industry. The company has successfully integrated its high-power wireless charging technology into Kenworth's Class 6 electric trucks, specifically the K270E and K370E models, marking the first OEM-approved high-power wireless charging integration of its kind. This milestone is the result of six months of collaborative engineering efforts between WAVE Charging, Kenworth, Dana Incorporated, and Inland Kenworth, showcasing the commitment to innovation and pushing the boundaries of electric vehicle technology.
|
AVXL | Hot Stocks07:37 EST Anavex reports publication of ANAVEX 3-71 human study in clinical journal - Anavex Life Sciences announced a peer-reviewed publication in Clinical Pharmacology in Drug Development, findings from the ANAVEX3-71 first-in-human study which achieved its safety objectives. The publication is entitled, 'Population-Based Characterization of the Pharmacokinetics and Food Effect of ANAVEX3-71, a Novel Sigma-1 Receptor and Allosteric M1 Muscarinic Receptor Agonist in Development for Treatment of Frontotemporal Dementia, Schizophrenia, and Alzheimer Disease'.1 The publication reports the Population-based characterization of the Pharmacokinetics and food effect of ANAVEX3-71 as part of the single ascending dose study in healthy participants with the primary objective of assessing dose proportionality of ANAVEX3-71, and to characterize the effect of food on the PK of ANAVEX3-71. The results from this PK evaluation demonstrated that ANAVEX3-71, at single ascending doses of 5 to 200 mg, is linear, dose proportional, and time invariant. Food had no effect on the PK of ANAVEX3-71. This data also expands the safety objectives met in this first-in-human study of ANAVEX3-71, further supporting its drug development program. While KarXT from Karuna Therapeutics, a muscarinic M1 receptor agonist, demonstrated weak benefits on cognitive impairments in individuals with Schizophrenia, ANAVEX3-71's dual-pharmacological action on SIGMAR1 and M1 muscarinic receptors is implicated in its pro-cognitive effects in murine Alzheimer's disease models and demonstrates its potential to treat cognitive and behavioral deficits in neurological diseases by affecting protein homeostasis in the central nervous system. "This published clinical study demonstrates Anavex's commitment to advance Anavex's clinical pipeline including ANAVEX3-71 for Schizophrenia, Frontotemporal Dementia, and Alzheimer's Disease," said Christopher U Missling, PhD, President and Chief Executive Officer of Anavex. "We are looking forward to reporting first patient dosed in the upcoming U.S. Phase 2 clinical trial in Schizophrenia with ANAVEX3-71."
|
CARS F | Hot Stocks07:36 EST Cars.com's AccuTrade selected by FordDirect as preferred commerce solution - Cars.com (CARS) announced that Ford's (F) FordDirect has selected AccuTrade, a Cars Commerce solution, as its preferred vehicle acquisition and trade and appraisal solution for The Shop, a newly launched e-commerce platform for 3000+ Ford dealers and Lincoln retailers. AccuTrade aims to speed transaction time by enabling digital instant offers for consumers while equipping everyone in the dealership with turnkey and transparent acquisition solutions that complete an accurate appraisal in under five minutes from anywhere. In 2023, AccuTrade generated more than 275,000 Instant Offers for consumers and retailers completed more than 1 million appraisals. Half of the retailers leveraging the AccuTrade solution in the service drive in 2023 at least doubled their volume of service drive appraisals from January to December.
|
ENDP | Hot Stocks07:34 EST Endo to present data on CCH in plantar fibromatosis - Endo announced that data from clinical studies of collagenase clostridium histolyticum - CCH - in patients with plantar fibromatosis will be presented during the American Orthopaedic Foot & Ankle Society's annual scientific meeting through September 23 in Louisville, Kentucky. Three presentations cover data from the Phase 1 clinical study of CCH in patients with plantar fibromatosis. Results demonstrated improvement in nodule hardness and in patient and physician satisfaction scores. In addition, the CCH safety profile was consistent with the known CCH safety profile from other clinical studies and indications. Most adverse events were rated as mild to moderate, and there were no reported treatment-related serious adverse events. A fourth presentation provides real-world treatment patterns.CCH is not approved for use in treating patients with plantar fibromatosis. Endo has completed a Phase 2 study and anticipates that the pivotal Phase 3 program will begin later this year.
|
ABT | Hot Stocks07:32 EST Abbott reports Q4 worldwide Medical Devices sales up 17.5% on reported basis - Worldwide Medical Devices sales increased 17.5% on a reported basis and 15.4% on an organic basis in the fourth quarter. Sales growth was led by double-digit organic growth in Diabetes Care, Neuromodulation, Structural Heart, Electrophysiology, Heart Failure, and Rhythm Management.
|
VERO | Hot Stocks07:31 EST Venus Concept announces review of strategic alternatives - Venus Concept's Board of Directors is evaluating potential strategic alternatives to maximize shareholder value. As part of the process, the Board is considering a full range of strategic alternatives, which may include one or more financings, mergers, reverse mergers, other business combinations, sales of assets, licensings or other transactions. The Company has retained Canaccord Genuity LLC as its financial advisor to assist in evaluating potential strategic alternatives. There can be no assurance that the evaluation of strategic alternatives will result in any transaction, nor can there be any assurance regarding any transaction's timing or ultimate outcome. Venus Concept has not set a timetable for completion of the process and does not intend to disclose developments related to the process unless and until the Company executes a definitive agreement with respect thereto, or the Board otherwise determines that further disclosure is appropriate or required.
|
MAIA | Hot Stocks07:20 EST MAIA publishes PCT application covering anticancer telomere-targeting compounds - MAIA Biotechnology company developing targeted immunotherapies for cancer announced that the World Intellectual Property Organization or WIPO, has published MAIA's global Patent Cooperation Treaty ,PCT, application titled "Dinucleotides and Their Use in Treating Cancer." These compounds are key next-generation telomere-targeting agents, an important extension of MAIA's innovative cancer treatment platform. The international patent application covers potential cancer therapies using dinucleotide compounds that target telomeres in cancer cells, and methods for using the dinucleotide compounds to treat cancers alone or before administration with checkpoint inhibitors CPIs . The new dinucleotides disclosed in the patent application are telomere-targeting molecules, such as THIO fragments or other THIO analogues. The PCT system streamlines the process for obtaining patent protection globally. Under the PCT, applicants can seek patent protection in a large number of countries. "This new IP would expand the value of our telomere-targeting compounds as first-in-class cancer treatments in regions around the world and provide patent coverage through 2043," said Vlad Vitoc, M.D., MAIA's Chairman and Chief Executive Officer. "Previous preclinical studies of several of our second-generation telomere-targeting agents have shown highly significant anti-cancer efficacy in multiple in vivo and in vitro models. Importantly, this new coverage would further cement our robust and transformational cancer treatment franchise."
|
HHH | Hot Stocks07:19 EST Howard Hughes appoints Joseph Valane as general counsel - Howard Hughes Holdings announced that Joseph Valane has been appointed General Counsel and Secretary of the company, effective March 18, 2024. Mr. Valane will oversee all legal matters for Howard Hughes and its national portfolio of award-winning communities. Valane previously served as General Counsel of Revantage and Shopcore Properties, two Blackstone portfolio companies.
|
LMT | Hot Stocks07:19 EST Lockheed Martin and Red 6 announce joint venture and mentor-protege agreement - Lockheed Martin and Red 6 announced a strategic joint venture and Mentor-Protege Agreement under the U.S. Small Business Administration Mentor-Protege Program. Lockheed Martin will gain access to small business teaming partner contracts and bring small business innovation to large programs / contracts. This includes potential Red 6 technology integration into current fighter platforms such as the F-16, F-22 and F-35, emerging trainers such as the TF-50, rotary vertical lift, airlift and new/future programs. Red 6 is a Lockheed Martin Ventures portfolio company selected in 2020 to accelerate the development and commercialization of Red 6's ATARS. In 2023, the partnership expanded to developing engineering solutions and a technology roadmap to establish an implementation path for Red 6's ATARS into the TF-50 program and associated ground-based training systems.
|
LOOP | Hot Stocks07:10 EST Loop Industries, Bormioli Pharma to unveil pharmaceutical packaging bottle - Loop Industries and Bormioli Pharma announced that a pharmaceutical packaging bottle manufactured with 100% recycled virgin quality Loop PET resin will be unveiled within the Bormioli booth at Pharmapack Europe 2024. Bormioli Pharma and Loop Industries aim to introduce market-ready solutions for the global pharmaceutical industry and the two companies began to collaborate over a year ago in order to achieve this goal. Bormioli Pharma tested Loop PET resin in its packaging, commissioning to independent third parties' additional analysis to verify extractables levels with different solutions, also taking in consideration the worst-case scenario. The results of these tests set a new benchmark for recycled plastic products within the pharmaceutical industry, as the bottles produced with Loop PET resin do not release any substance deemed of toxicological relevance.
|
HBT | Hot Stocks07:09 EST HBT Financial board increases quarterly dividend 2c to 19c per share - On January 23, 2024, the Company's Board of Directors declared a quarterly cash dividend of $0.19 per share on the Company's common stock. The Dividend is payable on February 13, 2024 to shareholders of record as of February 6, 2024. This represents an increase of $0.02 from the previous quarterly dividend of $0.17 per share. J. Lance Carter, President and Chief Executive Officer of HBT Financial, said, "Our strong financial performance and balance sheet enable us to increase our quarterly dividend by $0.02 per share, or 11.8%, while maintaining sufficient capital to support the continued growth of the Company."
|
VSAT | Hot Stocks07:08 EST ViaSat selected by Lufthansa Group for in-flight connectivity upgrades - Viasat has been selected by Lufthansa Group to equip more than 150 additional aircraft - across its Lufthansa, SWISS, and Austrian Airlines fleets - with the European Aviation Network in-flight connectivity solution. EAN combines S-band satellite coverage provided by Viasat with a complementary ground component network operated by long-standing Viasat and Lufthansa Group partner, Deutsche Telekom, delivering a service that supports streaming and other high bandwidth requirements. Inmarsat, which was recently acquired by Viasat, has provided its Ka-band IFC service to Lufthansa Group since 2015. This connectivity solution is already onboard 240 Lufthansa Group narrow-body aircraft. Lufthansa Group airlines recently unveiled a new release of its onboard portal, FlyNet, which will be accessible on EAN-equipped aircraft.
|
SF | Hot Stocks07:05 EST Stifel Financial board raises quarterly dividend 17% to 42c per share - The Board of Directors approved a 17% increase in the quarterly dividend to $0.42 per common share starting in the first quarter of 2024.
|
KMB | Hot Stocks07:05 EST Kimberly-Clark increases dividend 3.4% to $1.22 per share - Kimberly-Clark has declared an increased quarterly dividend of $1.22 per share, an 3.4% increase. The dividend is payable on April 2 to stockholders of record as of March 8.
|
TLRY TAP | Hot Stocks07:05 EST Tilray completes acquisition of Truss Beverage - Tilray Brands (TLRY) announced the completion of its acquisition of Truss Beverage from Molson Coors Beverage Company (TAP) and the satisfaction of remaining contractual obligations. Blair MacNeil, President, Tilray Canada, added, "Truss has elevated our market share and positions us at the forefront of adult-use beverages. We are now strengthening our Canadian operations to be better positioned to further expand our business and consumer base through new brand and product innovation and by serving new consumer segments and occasions."
|
TEF | Hot Stocks07:04 EST Telefonica, Nova Labs launch Helium Mobile Hotspots in Mexico - Telefonica and Nova Labs have partnered to launch Helium Mobile Hotspots in Mexico. The solution, implemented with select customers in Mexico City and Oaxaca, will extend Telefonica's coverage and enable offloading of mobile data to the Helium Mobile Network and improve overall mobile coverage service for customers. Telefonica and Nova Labs have built a solution based on the OpenWifi standard developed by the Telecom Infra Project. This solution enables select Movistar customers in Mexico to access the Helium Mobile Network using their Movistar SIM cards for authentication.
|
MOB | Hot Stocks07:04 EST Mobilicom's ICE Cybersecurity software solutions chosen by Israel's MoD - Mobilicom announced that its ICE Cybersecurity, the world's first AI-based 360 degrees software cybersecurity system for drones, has been chosen by Israel's Ministry of Defense, MoD, for its small-sized drone program. Mobilicom's proven solutions, including its ICE Suite and SkyHopper Pro datalinks were purchased for immediate delivery. The initial order was fully delivered in January 2024. Additional orders and deliveries are expected in Q2 2024 and beyond. "Israel's Ministry of Defense has thoroughly tested our ICE Cybersecurity software solution and validated its robust capabilities. Mobilicom has already commenced shipping our ICE Suite software solution bundled with the SkyHopper Pro datalinks to be incorporated into small-sized reconnaissance drones. These drones are immediately being delivered for surveillance and intelligence gathering," stated Mobilicom CEO and Founder Oren Elkayam.
|
GD | Hot Stocks07:03 EST General Dynamics reports Q4 net cash from operations $1.2B - During the year, the company reduced debt by $1.2B, invested $904M in capital expenditures, paid $1.4B in dividends, and used $434M to repurchase shares, ending 2023 with $1.9B in cash and equivalents on hand.
|
BITF | Hot Stocks07:02 EST Bitfarms purchases land in Paraguay for new 100MW production facility - Bitfarms announces that it has completed the purchase of land for its new 100 MW production facility in Yguazu, Paraguay. "This transaction, an important step in our recently announced transformative fleet upgrade, expands our LATAM portfolio with low-cost renewable hydropower," said Geoff Morphy, President and CEO of Bitfarms. "The newly acquired land is located in the heart of Paraguay near the Itaipu Dam, the third largest hydropower dam in the world with 14 gigawatts of installed capacity. Positioned to benefit from the region's abundant renewable energy resources, this new facility should be sustainable both economically and environmentally. Once Yguazu comes online, over 85% of our portfolio will be powered by low-cost green energy that promotes environmentally sustainable bitcoin mining."
|
THTX | Hot Stocks07:01 EST Theratechnologies receives CRL from FDA for 58 formulation of tesamorelin sBLA - Theratechnologies announced that the U.S. Food and Drug Administration, FDA, has issued a Complete Response Letter, CRL, in response to the Company's supplemental Biologics License Application for the F8 formulation of tesamorelin. The Company will address the FDA's request and intends to pursue approval of this newer formulation of tesamorelin. The questions outlined in the CRL are largely related to chemistry, manufacturing and controls concerning the microbiology, assays, impurities and stability for both the lyophilized product and the final reconstituted drug product. In addition, the FDA requested further information to understand the potential impact of the proposed formulation on immunogenicity risk. "While we are disappointed to receive a Complete Response Letter from the FDA for the F8 formulation of tesamorelin containing questions that were not raised during the review process, we plan to address these new comments as swiftly as possible," said Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer at Theratechnologies. "We remain focused on bringing this new formulation of tesamorelin to market as part of our commitment to innovate and simplify treatments for people with HIV."
|
GD | Hot Stocks07:01 EST General Dynamics ends Q4 with backlog of $93.6B
|
EXK | Hot Stocks06:56 EST Endeavour Silver provides 2024 update for Terronera Project, Mexico - Endeavour Silver announced its 2024 development update for the high-grade silver-gold Terronera Project in Jalisco state, Mexico. To date, the company has made construction progress with concrete work and vertical construction now underway. The company has updated its initial capital cost, schedule, and execution plan. The company anticipates the schedule to remain in line with previous guidance, with initial production anticipated to start in 4Q24. The Board approved an optimized Terronera Project construction scenario consisting of a process plant with 2,000 tons per day - tpd - capacity and an initial capital cost of $230M. Endeavour now forecasts initial capital costs to be 18% higher, at $271M. At the end of 2023, construction progress was approaching 50% completion. In Q2 and Q3, work is planned to advance in all plant areas with mechanical completion and commissioning activities planned in Q4 with initial production at the end of 2024. Development activities at La Luz are expected to begin in Q3 with portal construction and ramp advance to ore access in Q4. The project remains on schedule for mill commissioning and initial production in 4Q24. The company expects to make the first draw under the $120M project loan debt facility in 1Q24. Construction of the project remains on track and the funds available under the project loan debt facility will be allocated to fund construction. Terronera is expected to produce 4 million ounces of silver and 38,000 ounces of gold annually over its 10-year life.
|
MAG | Hot Stocks06:52 EST MAG Silver announces Q4, FY23 production from Juanicipio - MAG Silver reports production from Juanicipio and MAG, respectively) for the fourth quarter and year ended December 31, 2023. Q4 Highlights: Solid processing performance: Juanicipio processed 346,766 tonnes of mineralized material in Q4, up from 322,249 tonnes in Q3 reflecting ongoing efforts to ramp up production and optimize operations. Robust production: Juanicipio produced 4.5 million silver ounces and 10,591 gold ounces in Q4. Strong grades: The average silver head grade for the quarter was 467 grams per tonne, marginally lower than the previous quarter but offset by higher gold and base metal grades. This continues to demonstrate the high-grade nature of the Juanicipio deposit. Optionality maintained: Juanicipio continued to capitalise on available milling capacity at the Saucito plant (100% Fresnillo owned) to maintain processing rates during periods of maintenance. Approximately 5% of the material processed during Q4 was processed through the Saucito plant. 2023 Full Year Highlights: Processing growth: Juanicipio processed a total of 1,268,756 tonnes of mineralized material in 2023, exceeding expectations and achieving guidance of reaching nameplate during Q3 2023. Consistent processing growth quarter-on-quarter reflecting the commitment to scaling up operations. Record output: Juanicipio produced 16.8 million silver ounces and 36,732 gold ounces in 2023, a solid performance in its inaugural and ramp up year. Consistency: The average silver head grade for the year was 472 g/t, demonstrating the notable consistency of the Juanicipio deposit and solidifying its position as one of the highest grade silver mines in the world. As reported to MAG by the project operator Fresnillo, mining rates continued to ramp up during the quarter supporting the increased processing rate of 346,766 tonnes of mineralized material across the Juanicipio and Saucito plants. The average silver head grade for the quarter was 467 g/t, marginally below the previous quarter as mining sequenced through lower grade. This was mitigated by higher throughput delivering preliminary production estimates for the quarter, before any adjustments from offtake agreements, of 4.5 million silver ounces and 10,591 gold ounces. Juanicipio produced 16.8 million silver ounces and 36,732 gold ounces for the year. MAG expects to release its comprehensive financial and operational results on March 19, 2023.
|
BW BKH | Hot Stocks06:40 EST Babcock & Wilcox, Black Hills Energy receive Wyoming hydrogen facility grant - Babcock & Wilcox (BW) and Black Hills (BKH) Energy have received a $16M grant from the Wyoming Energy Authority to fund the permitting, engineering and development activities for a clean hydrogen generation facility with carbon dioxide capture and sequestration at Black Hills Energy's Neil Simpson Power Plant in Gillette, Wyo. The plant design intends to use B&W's BrightLoop technology to produce clean energy from coal, while CO2 emissions will be sequestered, or put to beneficial use. As designed, the plant will be capable of producing 15 tons of clean hydrogen per day utilizing the BrightLoop process, which is a patented chemical looping technology. B&W's BrightLoop chemical looping technology is part of its ClimateBright suite of decarbonization and hydrogen technologies.
|
DNN | Hot Stocks06:37 EST Orano Canada, Denison Mines announce MJLV approval to restart McClean operations - Orano Canada and Denison Mines, as joint-venture partners in the McClean Lake Joint Venture, or MLJV, announced that the MLJV has approved a restart of uranium mining operations using the joint venture's patented Surface Access Borehole Resource Extraction, or SABRE, mining method. Orano Canada owns a 77.5% interest and is the operator of the MLJV and Denison owns a 22.5% interest. Mining is planned to commence at the McClean North deposit in 2025, with 2024 activities expected to focus on preparations necessary to ready the existing SABRE mining site and equipment for continuous commercial operations, as well as the installation of eight pilot holes for the first mining cavities planned for excavation. The approved budget for this work in 2024 is $7M. Approximately 800,000 pounds U3O8 are targeted for production from McClean North in 2025, with approximately 3,000,000 pounds U3O8 identified for potential additional production from a combination of the McClean North and Caribou deposits during the years 2026 to 2030.
|
FRGT | Hot Stocks06:36 EST Freight Technologies announces CFO transition - Freight Technologies announced changes to its executive team and board of directors. Paul Freudenthaler, former CFO, has been appointed as a member of the board of directors of the company effective January 19. Simultaneously, Fr8Tech appointed Don Quinby as its new CFO. Quinby most recently played roles in FP&A and investor relations in the 2023 IPO of Nextracker, a company in the solar tracker industry.
|
NXU | Hot Stocks06:34 EST Nxu Inc. secures EV charging patents - Nxu, Inc. has secured a patent showcasing a novel component found on Nxu's differentiated NxuOne EV Charging Solutions. Patent US 11,813,949 B2 protects the design for a locking mechanism in the NxuOne charging handle. Nxu was issued a second patent, US 11,616,277 B2, protecting Nxu's proprietary thermal management solution for electric vehicle batteries. Nxu's patent portfolio continues to grow, demonstrating its dedication to protecting the intellectual property it intends to fully deploy toward solving America's EV charging infrastructure challenges, making powerful, fast, consistent charging solutions a reality from vehicle to charger to energy storage and back.
|
HUT | Hot Stocks06:33 EST Hut 8 Corp. responds to 'misleading' short report - Hut 8 Corp. issued the following statement regarding a report from an activist short-selling firm containing false and misleading characterizations about Hut 8's business. "Hut 8 has assessed the claims set forth by the authors of the report and believes that the report is filled with inaccuracies, misrepresented data, speculative claims, and unfounded character attacks. The report appears to represent a deliberate attempt to spread misinformation about Hut 8, its operations, finances, management practices, and key executives. The statements made by the short seller expose an inadequate, distorted understanding of the Company, its operations, and its key executives. The report appears to have been made to distract from the Company's achievements and progress since closing its merger of equals. The Company believes that the report was designed for the sole purpose of negatively impacting Hut 8's share price for the short seller's own benefit, at the expense of Hut 8's shareholders, partners, and employees." "The Board maintains full confidence in the company's merger of equals, strategic plan, and management team," said Bill Tai, Chairman of Hut 8's Board of Directors. "Our focus remains on the long-term vision and continued success of Hut 8. We remain committed to ensuring that our governance and oversight are aligned with the best interest of our stakeholders." "The Company continues to focus on driving strong operating and financial results. On December 31, 2023, Hut 8 held 9,195 Bitcoin in reserve, with an approximate value of $390 million, and had North American-wide operations spanning 205,759 miners under management. In addition to its strong balance sheet, Hut 8 is distinguished from its peers by its diversified business, as approximately 30% of its revenue was generated from fiat revenue streams as of September 30, 2023. "Since I joined as CEO more than three years ago, our leadership team and I have worked tirelessly to earn investors' and analysts' confidence in our operations, our diversified strategy, and our growth trajectory. We will not be derailed by activists who stand to profit from spreading misinformation and making defamatory character attacks," said Hut 8 CEO Jaime Leverton. "The short report is riddled with speculative accusations and misinformation. Our Board of Directors and management team continue to have full confidence in our merger of equals and we look forward to showing our team, shareholders, and the broader investment community that together, we are not only stronger than the sum of our parts, but we are also poised to capture upside as we move forward as a unified team." Hut 8 cautions investors to not make decisions based on the report and instead strongly encourages them to consult credible sources, including the Company's filings with the U.S. Securities and Exchange Commission and the Canadian securities regulatory authorities, prior to making their investment decisions.
|
ASML | Hot Stocks06:09 EST ASML intends to declare 2023 dividend of EUR 6.10 per share - ASML intends to declare a total dividend for the year 2023 of EUR 6.10 per ordinary share, which is a 5.2% increase compared to 2022. An interim dividend of EUR 1.45 per ordinary share will be made payable on February 14, 2024.
|
ELV | Hot Stocks06:08 EST Elevance Health reports Medical membership totaled ~47M at Dec. 31, 2023 - A decrease of 570,000 or 1% year-over-year. "This was driven by attrition in our Medicaid business associated with the resumption of eligibility redeterminations in the second quarter of 2023 and declines in our Employer Group risk-based business. These membership losses were partially offset by growth in BlueCard, Affordable Care Act health plans, and Medicare Advantage."
|
RDNT | Hot Stocks06:08 EST RadNet's radiology Joint Venture acquires seven imaging centers in Arizona - RadNet's joint ventured Arizona Diagnostic Radiology has acquired seven outpatient imaging centers in Phoenix Arizona from Evernorth Care Group. The acquisition will expand outpatient imaging services for Evernorth Care Group patients, who will now have access to Arizona Diagnostic Radiology's nine additional imaging centers in the Phoenix market. Additionally, the newly acquired imaging centers will implement RadNet's digital health solutions, including radiology information and image management systems and DeepHealth's artificial intelligence platform.
|
GOEV | Hot Stocks06:05 EST Canoo receives purchase order for 6 electric vehicles from U.S.Postal Service - Canoo announced the U.S. Postal Service will purchase six battery-electric Canoo vehicles. The Postal Service will take delivery of these six right-hand drive versions of the LDV 190 in Q1. This effort is part of the USPS's $40B investment strategy to upgrade and improve the organization's processing, transportation, and delivery networks.
|
LPG | Hot Stocks06:05 EST Dorian LPG declares irregular cash dividend of $1.00 per share - Dorian LPG announced that its Board of Directors has declared an irregular cash dividend of $1.00 per share of the company's common stock. The total dividends to be paid will amount to approximately $40.6M. The dividend is payable on or about February 27 to all shareholders of record as of the close of business on February 5.
|
CVX | Hot Stocks06:04 EST Chevron Shipping President Mark Ross to retire, Barbara Pickering succeeds - Cheveron announced that Mark Ross, President of Chevron Shipping Company, has elected to retire effective May 1. Barbara Pickering, currently VP of Operations, Chevron Shipping Company, will succeed Mark as President. Ross has led Chevron Shipping Company since 2015. Prior to that, he served as Vice President of Operations of the company for four years. He joined Chevron in 1990. Pickering joined Chevron in 1991 as a ship charterer in London. She has held positions of increasing responsibility with Chevron in the UK, Australia, and the United States. She also currently serves as a Vice Chairman of Oil Companies International Marine Forum.
|
ELV | Hot Stocks06:03 EST Elevance Health raises quarterly dividend 10.1% to $1.63 per share
|
BA DAL | Hot Stocks06:02 EST Boeing 757 operated by Delta lost nose wheel ahead of takeoff, FAA says - A Boeing (BA) 757 plane operated by Delta (DAL) lost a nose wheel as it prepared to take off from Atlanta's main airport on Saturday, the FAA said in a preliminary report. Delta Flight 982 was preparing to take off from Hartsfield-Jackson Atlanta International Airport for a trip to Bogota, Colombia, on Saturday when a "nose wheel came off and rolled down the hill." More than 170 passengers who were aboard had to deplane, but no one was hurt, the report said. Reference Link
|
RIO | Hot Stocks06:00 EST Rio Tinto to drive development of Australia's solar farm at Gladstone - Rio Tinto announced that it will drive development of Australia's largest solar power project near Gladstone, after agreeing to buy all electricity from the 1.1GW Upper Calliope Solar Farm to provide renewable power to Rio Tinto's Gladstone operations. Under a new power purchase agreement signed with European Energy Australia, Rio Tinto will buy all power generated from the Upper Calliope solar farm for 25 years. The plant will be built and operated by European Energy, at a site about 50 kilometres south-west of Gladstone, pending development and grid connection approvals. Once approved and developed, Upper Calliope would have the potential to lower Rio Tinto's operating carbon emissions by 1.8 million tonnes per year. Rio Tinto CEO Jakob Stausholm said "This agreement is a first important step in our work to repower our Gladstone operations and illustrates our commitment to keeping sustainably powered industry in Central Queensland."
|
RIO | Hot Stocks05:32 EST Rio Tinto announces fatal plane crash on way to Diavik mine - The company said, "We have been informed by authorities that a plane on its way to our Diavik mine, carrying a number of our people, crashed near Fort Smith, Northwest Territories, Canada, resulting in fatalities." Rio Tinto CEO, Jakob Stausholm said: "I would like to extend our deepest sympathy to the families, friends, and loved ones of those who have been affected by this tragedy. As a company we are absolutely devastated by this news and offering our full support to our people and the community who are grieving today. We are working closely with authorities and will help in any way we can with their efforts to find out exactly what has happened."
|
NOK | Hot Stocks05:16 EST Nokia signs multi-year patent cross-license agreement with Oppo - Nokia announced it has signed a multi-year patent cross-license agreement with Oppo. Under the agreement Oppo will make royalty payments, along with catch-up payments to cover the periods of non-payment. The agreement resolves all pending patent litigation between the parties, in all jurisdictions. The terms of the agreement remain confidential as agreed between the parties.
|
SLI | Hot Stocks05:13 EST Standard Lithium selects Ausenco to complete DFS, FEED services for SWA project - Standard Lithium announced the selection of Ausenco Engineering Canada to complete the Definitive Feasibility Study, or DFS, and Front-End Engineering and Design, or FEED, services for the South West Arkansas, or SWA, Project.
|
CSIQ BLK | Hot Stocks05:10 EST Canadian Solar subsidiary secures $500M investment from BlackRock - Yesterday, Recurrent Energy, a subsidiary of Canadian Solar (CSIQ), and a global developer and owner of solar and energy storage assets, announced that Recurrent Energy B.V. has secured a $500M preferred equity investment commitment, convertible into common equity, from BlackRock (BLK) through a fund managed by its Climate Infrastructure business. The $500M investment will represent 20% of the outstanding fully diluted shares of Recurrent Energy on an as-converted basis. Canadian Solar will continue to own the remaining majority shares of Recurrent Energy after the closing of the investment. The investment will provide Recurrent Energy with additional capital to grow its project development pipeline while executing its strategy to transition from a pure developer to a developer plus long-term owner and operator in select markets including the U.S. and Europe.
|